<?xml version="1.0" encoding="UTF-8"?>
<svg height="741.339" width="548.5790000000001" xmlns="http://www.w3.org/2000/svg">
 <g>
  <text y="95.358" x="56.693,60.106,63.519,64.794,71.716,75.721,79.504,81.577,83.059,85.653,87.804,89.286,92.471,96.255,98.955,100.969,105.422,106.697,108.736,111.999,114.073,117.257,121.041,123.634,127.489,131.272,133.345,135.595,137.649,141.503,143.577,147.36,149.512,152.925,154.407,158.19,160.89,162.934,166.119,169.902,173.952,175.916,177.398,181.181,183.333,186.746,189.339,191.491,192.973,196.756,199.941,201.516,203.581,209.367,212.78,214.931,218.116,221.971,225.754,227.236,228.718,231.311,237.097,238.372,240.431,243.993,246.066,249.921,251.403,254.516,257.63,261.413,265.268,267.341,271.125,273.276,276.689,278.171" svgx:width="0.48,0.48,0.17,0.55,0.56,0.53,0.29,0.21,0.36,0.3,0.21,0.45,0.53,0.36,0.55,0.63,0.17,0.55,0.46,0.29,0.45,0.53,0.36,0.54,0.53,0.29,0.3,0.55,0.54,0.29,0.53,0.3,0.48,0.21,0.53,0.36,0.55,0.45,0.53,0.54,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.81,0.48,0.3,0.45,0.54,0.53,0.21,0.21,0.36,0.81,0.17,0.55,0.5,0.29,0.54,0.21,0.44,0.44,0.53,0.54,0.29,0.53,0.3,0.48,0.21,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">58. Christians U. Transport proteins and intestinal metabolism: P-glycoprotein</text>
  <text y="104.315" x="71.716,74.901,78.685,82.735,84.642,87.756,90.87,93.021,96.805,99.918,103.702,105.775,109.558,115.344,118.94399999999999,120.925,124.488,127.901,131.313,134.726,138.139,142.293,143.568,145.643,148.906,152.69,156.102,158.27700000000002,160.27,164.865,166.939,170.644,174.69400000000002,176.653,182.14,185.923,189.706,191.188,193.34,194.615,196.666,200.079,203.492,206.904,210.317,211.5,214.913,218.326,219.508,222.921,226.334" svgx:width="0.45,0.53,0.54,0.55,0.44,0.44,0.3,0.53,0.44,0.53,0.29,0.53,0.81,0.48,0.55,0.5,0.48,0.48,0.48,0.48,0.58,0.17,0.55,0.46,0.53,0.48,0.29,0.55,0.64,0.29,0.52,0.54,0.55,0.77,0.53,0.53,0.21,0.3,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and cytochrome P4503A. Ther Drug Monit. 2004;26:104</text>
  <text y="104.315" x="229.777" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="104.315" x="233.348,236.761" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">6.</text>
  <text y="113.555" x="56.693,60.106,63.519,64.794,71.716,74.98,78.763,82.468,88.253,94.039,97.452,99.027,101.082,104.567,107.83,109.105,111.117,115.492,119.197,121.447,123.533,125.015,128.798,131.392,133.543,135.025,138.809,141.922,144.074,146.668,147.943,149.951,153.956,157.518,161.081,164.493,168.647,172.24699999999999,174.215,177.4,181.183,185.233,187.198,188.68,192.463,194.615,198.027,200.621,202.773,204.255,208.038,211.223,212.798,214.863,218.717,220.791,224.496,228.54600000000002,230.51,236.295,239.708,241.86,245.045,248.899,252.683,254.165,255.646,258.24,264.025,265.29999999999995,267.359,269.909,271.951,275.955,277.437,278.919" svgx:width="0.48,0.48,0.17,0.55,0.46,0.53,0.52,0.81,0.81,0.48,0.21,0.55,0.49,0.46,0.17,0.55,0.61,0.52,0.3,0.55,0.21,0.53,0.36,0.3,0.21,0.53,0.44,0.3,0.36,0.17,0.55,0.56,0.5,0.5,0.48,0.58,0.48,0.55,0.45,0.53,0.54,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.54,0.29,0.52,0.54,0.55,0.81,0.48,0.3,0.45,0.54,0.53,0.21,0.21,0.36,0.81,0.17,0.55,0.34,0.55,0.56,0.21,0.21,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">59. Thummel KE. Gut instincts: CYP3A4 and intestinal drug metabolism. J Clin</text>
  <text y="122.569" x="71.716,73.198,76.982,80.167,83.579,86.173,88.325,89.60000000000001,91.615,95.028,98.441,101.853,105.266,106.449,109.862,113.275,116.687,117.87,121.283,124.696,128.109" svgx:width="0.21,0.53,0.45,0.48,0.36,0.3,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Invest. 2007;117:3173</text>
  <text y="122.569" x="131.528" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="122.569" x="135.1,138.512" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">6.</text>
  <text y="131.81" x="56.693,60.106,63.519,64.794,71.716,76.091,79.276,82.981,86.095,89.878,93.291,95.466,97.511,101.886,103.161,105.221,108.485,111.669,113.821,115.973,119.678,121.751,126.867,130.052,132.227,134.247,137.81,139.085,141.164,143.607,147.391,151.174,154.587,157.28699999999998,159.305,164.791,168.795,170.07,172.117,175.38,179.085,181.159,183.31,187.094,189.79399999999998,191.846,196.0,197.275,199.329,202.514,205.927,208.0,211.784,215.488,218.713,220.702,223.146,227.15,228.425,230.453,234.015,237.799,239.281,242.394,248.18,251.592,253.666,255.148,258.448,260.443,266.228,267.71,270.824,274.237,275.719,277.201,280.614" svgx:width="0.48,0.48,0.17,0.55,0.61,0.45,0.52,0.44,0.53,0.48,0.29,0.55,0.61,0.17,0.55,0.46,0.45,0.3,0.3,0.52,0.29,0.72,0.45,0.29,0.55,0.5,0.17,0.55,0.34,0.53,0.53,0.48,0.36,0.55,0.77,0.56,0.17,0.55,0.46,0.52,0.29,0.3,0.53,0.36,0.55,0.58,0.17,0.55,0.45,0.48,0.29,0.53,0.52,0.43,0.55,0.34,0.56,0.17,0.55,0.5,0.53,0.21,0.44,0.81,0.48,0.29,0.21,0.44,0.55,0.81,0.21,0.44,0.48,0.21,0.21,0.48,0.36" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">60. Gaucher G, Satturwar P, Jones MC, Furtos A, Leroux JC. Polymeric micelles</text>
  <text y="140.824" x="71.716,73.569,77.352,79.527,81.524,85.307,87.381,90.565,92.14,94.223,98.077,100.151,103.855,107.905,109.87,113.724,117.137,118.619,120.101,123.286,126.699,128.772,131.886,133.161,135.211,138.474,142.179,144.354,146.379,148.929,150.971,154.533,158.317,161.502,163.575,169.64999999999998,171.55,175.112,176.594,180.378,184.232,188.016,191.2,193.274,199.059,200.334,202.39,205.803,209.216,212.629,216.041,217.224,220.637,224.05,225.232,228.645,232.058" svgx:width="0.26,0.53,0.29,0.55,0.53,0.29,0.45,0.21,0.55,0.54,0.29,0.52,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.17,0.55,0.46,0.52,0.29,0.55,0.34,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.5,0.21,0.53,0.54,0.53,0.45,0.29,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">for oral drug delivery. Eur J Pharm Biopharm. 2010;76:147</text>
  <text y="140.824" x="235.446" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="140.824" x="239.018,242.43,245.843" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">58.</text>
  <text y="150.065" x="56.693,60.106,63.519,64.794,71.716,76.091,79.654,81.808,84.529,88.384,91.673,95.528,97.115,100.265,103.011,106.356,107.631,110.495,114.18,117.593,121.55,123.138,125.348,128.723,131.472,134.817,136.092,138.956,142.641,146.496,149.161,150.748,153.016,154.498,157.834,161.349,162.937,166.23700000000002,169.003,172.178,176.033,179.32,181.491,185.346,188.918,192.96800000000002,195.721,198.412,201.923,203.502,205.452,207.623,211.134,217.017,220.819,222.399,225.09,226.669,228.62,231.831,233.313,237.273,241.323,244.076,247.957,249.537,251.112,253.959,255.887,259.768,261.938,267.724,271.576,273.156,276.438,278.649,280.237,284.118" svgx:width="0.48,0.48,0.17,0.55,0.61,0.48,0.29,0.36,0.53,0.45,0.53,0.21,0.42,0.55,0.46,0.17,0.55,0.5,0.48,0.53,0.21,0.3,0.45,0.55,0.46,0.17,0.55,0.5,0.53,0.36,0.21,0.3,0.21,0.45,0.48,0.21,0.44,0.55,0.44,0.53,0.45,0.29,0.54,0.48,0.54,0.55,0.36,0.48,0.21,0.26,0.29,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.44,0.21,0.53,0.54,0.55,0.53,0.21,0.21,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">61. Gershanik T, Benita S. Positively charged self-emulsifying oil formulation</text>
  <text y="159.079" x="71.717,73.665,77.544,79.719,82.59,84.072,90.017,93.985,96.154,100.033,103.313,104.891,108.77,112.82,115.572,119.451,121.62,124.9,126.47500000000001,129.322,133.177,134.821,138.7,141.98,145.26,148.541,150.118,151.6,154.937,158.887,160.464,161.946,163.582,165.829,169.12900000000002,171.895,175.774,177.724,180.593,184.447,186.659,190.538,194.392,197.965,200.686,202.897,206.411,208.58,212.459,216.338,219.846,221.121,223.928,227.613,231.492,234.772,236.941,243.016,245.672,250.363,253.871,257.246,259.994,263.339,266.848,270.022,273.901,277.78,281.659,283.236" svgx:width="0.26,0.53,0.29,0.55,0.21,0.81,0.54,0.29,0.53,0.45,0.21,0.53,0.54,0.55,0.53,0.29,0.45,0.21,0.55,0.54,0.21,0.53,0.45,0.45,0.45,0.21,0.21,0.45,0.54,0.21,0.21,0.21,0.3,0.44,0.55,0.53,0.26,0.55,0.54,0.29,0.53,0.54,0.48,0.36,0.3,0.48,0.29,0.53,0.53,0.48,0.17,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.64,0.48,0.45,0.55,0.46,0.48,0.44,0.53,0.53,0.53,0.21,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">for improving oral bioavailability of progesterone. Pharm Dev Technol.</text>
  <text y="168.093" x="71.717,75.13,78.69,82.209,85.727,86.974,90.493,91.781,95.194,98.754" svgx:width="0.48,0.48,0.48,0.48,0.17,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1996;1:147</text>
  <text y="168.093" x="102.274" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="168.093" x="105.902,109.417,112.932" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">57.</text>
  <text y="177.334" x="56.693,60.106,63.519,64.794,71.716,76.091,79.504,81.577,84.171,87.954,91.139,94.922,96.404,99.554,101.479,104.743,106.018,108.113,111.675,115.088,118.871,121.686,125.098,128.882,132.857,134.758,138.021,139.296,141.391,144.953,148.366,152.149,153.631,155.783,159.158,161.12,164.383,165.65800000000002,167.696,169.178,172.961,175.113,178.526,180.599,183.784,186.898,189.049,190.531,194.315,198.29,200.237,204.02,205.97,208.004,211.379,213.333,215.927,219.339,220.821,222.674,224.747,228.16,233.945,237.65,239.132,241.726,243.208,245.06,248.174,249.656,253.439,257.489,259.48,260.962,262.444,266.299,267.781,271.831,273.767,277.621,279.694,283.399" svgx:width="0.48,0.48,0.17,0.55,0.61,0.48,0.29,0.36,0.53,0.45,0.53,0.21,0.42,0.55,0.46,0.17,0.55,0.5,0.48,0.53,0.4,0.48,0.53,0.53,0.55,0.46,0.17,0.55,0.5,0.48,0.53,0.21,0.3,0.45,0.55,0.46,0.17,0.55,0.21,0.53,0.3,0.48,0.29,0.45,0.44,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.45,0.55,0.36,0.48,0.21,0.26,0.29,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.44,0.21,0.53,0.54,0.55,0.21,0.21,0.54,0.21,0.54,0.55,0.54,0.29,0.52,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">62. Gershanik T, Benzeno S, Benita S. Interaction of a self-emulsifying lipid drug</text>
  <text y="186.348" x="71.716,75.571,78.984,80.466,81.948,85.133,88.545,90.619,93.919,95.867,98.46,101.574,104.168,106.319,109.732,115.807,117.636,122.752,124.234,126.386,130.361,132.319,134.471,138.254,141.85399999999998,143.828,147.241,150.426,153.839,155.912,158.064,161.477,165.52700000000002,167.469,169.542,172.727,174.977,177.05,178.532,182.315,184.467,187.879,190.473,192.625,194.107,197.89,201.075,202.64999999999998,204.659,210.444,214.149,217.262,221.046,223.639,227.014,228.979,232.164,234.86399999999998,236.917,240.292,242.246,244.098,247.803,251.587,254.7,256.852,258.334,262.117,266.09200000000004,268.041,271.824" svgx:width="0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.55,0.72,0.21,0.3,0.53,0.55,0.3,0.53,0.48,0.55,0.48,0.45,0.48,0.29,0.3,0.48,0.54,0.55,0.29,0.45,0.3,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.81,0.52,0.44,0.53,0.36,0.45,0.55,0.45,0.36,0.55,0.45,0.55,0.26,0.52,0.53,0.44,0.3,0.21,0.53,0.53,0.55,0.53,0.26" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">delivery system with the everted rat intestinal mucosa as a function of</text>
  <text y="195.305" x="71.716,75.571,77.644,81.428,85.282,86.764,90.177,92.427,94.45,97.043,98.525,101.34,104.94,106.922,110.107,113.89,117.94,119.848,122.441,126.146,128.22,130.072,133.257,136.371,139.971,141.958,145.072,148.855,152.04,154.113,157.968,161.38,162.655,164.748,168.31,172.094,175.278,177.352,183.427,185.27,188.833,192.246,194.839,196.114,198.139,201.552,204.965,208.378,211.791,212.973,216.386,219.799,220.982,224.395,227.807" svgx:width="0.54,0.29,0.53,0.54,0.21,0.48,0.3,0.55,0.36,0.21,0.4,0.48,0.55,0.45,0.53,0.54,0.55,0.36,0.52,0.29,0.26,0.45,0.44,0.48,0.55,0.44,0.53,0.45,0.29,0.54,0.48,0.17,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.5,0.48,0.36,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">droplet size and surface charge. Pharm Res. 1998;15:863</text>
  <text y="195.305" x="231.251" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="195.305" x="234.823,238.235" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">9.</text>
  <text y="204.603" x="56.693,60.106,63.519,64.794,71.716,76.091,79.504,81.577,84.171,87.954,91.139,94.922,96.404,99.554,101.479,104.743,106.018,108.113,112.566,115.75,117.232,119.384,123.168,126.58,128.755,130.789,134.052,135.327,137.365,140.55,143.963,147.746,149.92100000000002,151.992,155.996,161.482,162.757,164.805,168.367,171.78,175.563,177.045,179.197,182.572,184.534,187.797,189.072,191.11,195.114,198.897,202.082,204.156,208.01,211.423,213.496,217.351,220.764,224.618,228.031,231.814,235.669,239.082,242.865,245.115,247.178,248.66,252.443,254.595,258.008,260.081,263.266,266.379,268.531,270.013,273.796,277.771,279.719,283.502" svgx:width="0.48,0.48,0.17,0.55,0.61,0.48,0.29,0.36,0.53,0.45,0.53,0.21,0.42,0.55,0.46,0.17,0.55,0.63,0.45,0.21,0.3,0.53,0.48,0.29,0.55,0.46,0.17,0.55,0.45,0.48,0.53,0.29,0.55,0.56,0.77,0.17,0.55,0.5,0.48,0.53,0.21,0.3,0.45,0.55,0.46,0.17,0.55,0.56,0.53,0.45,0.29,0.54,0.48,0.29,0.54,0.48,0.54,0.48,0.53,0.54,0.48,0.53,0.3,0.55,0.21,0.53,0.3,0.48,0.29,0.45,0.44,0.3,0.21,0.53,0.53,0.55,0.53,0.26" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">63. Gershanik T, Haltner E, Lehr CM, Benita S. Charge-dependent interaction of</text>
  <text y="213.56" x="71.716,74.31,77.723,79.205,81.057,84.47,90.255,93.96,95.442,98.036,99.518,101.37,104.484,105.966,109.749,113.79899999999999,115.766,119.549,121.031,122.60600000000001,124.61,126.463,130.246,132.319,138.105,141.81,143.292,146.477,148.628,150.11,153.894,157.677,160.37699999999998,162.481,167.596,169.078,171.23,175.20499999999998,177.107,181.111,184.296,187.41,191.193,193.267,196.867,198.877,201.99,205.403,206.885,208.367,211.06699999999998,213.107,218.892,222.675,226.459,230.242,231.724,234.909,238.022,241.435,243.509,246.102,247.377,249.446,253.3,254.782,258.566,262.42,263.902,267.685" svgx:width="0.36,0.48,0.21,0.26,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.44,0.21,0.53,0.54,0.55,0.53,0.21,0.21,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.36,0.55,0.72,0.21,0.3,0.53,0.55,0.56,0.45,0.44,0.53,0.29,0.48,0.55,0.44,0.48,0.21,0.21,0.36,0.55,0.81,0.53,0.53,0.53,0.21,0.45,0.44,0.48,0.29,0.36,0.17,0.55,0.54,0.21,0.53,0.54,0.21,0.53,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">selfemulsifying oil formulations with Caco-2 cells monolayers: binding</text>
  <text y="222.574" x="71.716,75.129,76.982,78.834,82.247,85.361,87.512,90.212,92.239,96.022,99.997,101.933,105.788,108.973,111.046,113.119,114.601,118.014,120.189,122.229,124.082,127.787,131.57,134.683,136.835,138.317,142.101,146.076,148.024,151.209,154.992,159.042,161.006,164.12,167.234,169.385,173.169,175.32,179.104,182.146,183.628,186.742,188.224,190.375,193.489,194.764,196.835,198.317,202.101,204.351,206.416,208.966,210.952,214.514,218.298,221.483,223.556,229.341,230.616,232.721,236.134,239.547,242.96,246.373,247.556,250.968,254.381,257.794,258.977,262.39" svgx:width="0.48,0.26,0.26,0.48,0.44,0.3,0.36,0.55,0.53,0.53,0.55,0.54,0.45,0.29,0.29,0.21,0.48,0.29,0.55,0.26,0.52,0.53,0.44,0.3,0.21,0.53,0.53,0.55,0.45,0.53,0.54,0.55,0.44,0.44,0.3,0.53,0.3,0.53,0.43,0.21,0.44,0.21,0.3,0.44,0.17,0.55,0.21,0.53,0.3,0.55,0.34,0.55,0.5,0.53,0.45,0.29,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">effects on barrier function and cytotoxicity. Int J Pharm. 2000;211:29</text>
  <text y="222.574" x="265.777" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="222.574" x="269.348,272.761,276.174" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">36.</text>
  <text y="231.814" x="56.693,60.106,63.519,64.794,71.716,76.091,78.165,81.349,83.501,85.653,89.436,93.411,95.357,98.62,101.883,106.037,107.31200000000001,109.359,112.922,116.705,120.56,124.61,126.537,130.099,134.253,135.528,137.592,141.154,144.938,148.721,150.203,153.986,157.171,160.876,163.576,165.598,169.16,173.756,175.031,177.106,180.291,183.996,185.848,188.098,190.145,192.589,196.593,197.868,199.896,205.382,208.567,212.422,216.276,219.689,223.664,225.634,229.197,231.641,232.916,234.989,239.513,242.698,246.552,248.034,251.447,253.622,255.681,261.167,264.43" svgx:width="0.48,0.48,0.17,0.55,0.61,0.29,0.45,0.3,0.3,0.53,0.53,0.55,0.46,0.46,0.58,0.17,0.55,0.5,0.53,0.54,0.54,0.55,0.5,0.58,0.17,0.55,0.5,0.53,0.53,0.21,0.53,0.45,0.52,0.36,0.55,0.5,0.64,0.17,0.55,0.45,0.52,0.26,0.3,0.55,0.34,0.56,0.17,0.55,0.77,0.45,0.54,0.54,0.48,0.53,0.55,0.5,0.34,0.17,0.55,0.63,0.45,0.54,0.21,0.48,0.29,0.55,0.77,0.46,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">64. Gratton SEA, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME,</text>
  <text y="240.829" x="71.716,76.312,79.725,82.988,84.47,90.255,94.039,97.822,101.422,103.35,105.794,111.28,112.555,114.632,117.895,121.678,125.27799999999999,127.217,130.63,132.483,134.335,137.748,140.862,143.112,145.132,148.915,150.86499999999998,152.956,156.811,159.995,162.069,164.22,165.702,168.816,170.298,173.898,175.86,179.714,183.127,185.721,187.203,191.057,195.03199999999998,196.949,200.733,204.708,206.701,209.814,213.227,214.709,216.191,219.896,221.378,224.563,226.738,228.754,230.236,234.019,236.171,239.583,241.657,245.44,248.625,250.107,251.589,254.403,257.588,259.74,261.222,265.005" svgx:width="0.64,0.48,0.46,0.21,0.81,0.53,0.53,0.48,0.55,0.34,0.77,0.17,0.55,0.46,0.53,0.48,0.55,0.48,0.26,0.26,0.48,0.44,0.3,0.55,0.53,0.26,0.55,0.54,0.45,0.29,0.3,0.21,0.44,0.21,0.48,0.55,0.54,0.48,0.36,0.21,0.54,0.53,0.55,0.53,0.53,0.55,0.44,0.48,0.21,0.21,0.52,0.21,0.45,0.29,0.55,0.21,0.53,0.3,0.48,0.29,0.53,0.45,0.21,0.21,0.4,0.45,0.3,0.21,0.53,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">DeSimone JM. The effect of particle design on cellular internalization</text>
  <text y="249.843" x="71.716,75.571,78.756,80.908,84.691,89.807,92.991,96.105,98.698,99.973,102.046,105.609,107.682,111.466,114.76599999999999,116.673,121.197,124.382,126.534,128.109,130.166,134.319,137.433,140.618,144.668,146.663,149.926,153.04,154.61499999999998,156.641,161.36599999999999,163.217,166.667,168.603,172.757,174.032,176.086,179.499,182.912,186.325,189.738,190.92,194.333,197.746,201.159,202.342,205.754,209.167,212.58,215.993" svgx:width="0.54,0.45,0.3,0.53,0.72,0.45,0.44,0.36,0.17,0.55,0.5,0.29,0.53,0.44,0.55,0.63,0.45,0.3,0.21,0.55,0.58,0.44,0.45,0.54,0.55,0.46,0.44,0.21,0.55,0.63,0.55,0.46,0.55,0.58,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">pathways. Proc Natl Acad Sci U S A. 2008;105:11613</text>
  <text y="249.843" x="219.458" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="249.843" x="222.973,226.386" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">8.</text>
  <text y="259.083" x="56.692,60.105,63.518,64.793,71.716,75.278,78.463,82.246,85.659,88.659,90.594,93.038,97.192,98.467,100.515,106.301,109.486,113.269,117.319,119.28,122.543,128.329,130.773,132.048,134.076,137.561,141.344,144.757,150.542,153.955,157.068,160.481,162.656,164.746,166.228,172.014,173.28900000000002,175.347,181.133,182.615,184.688,186.84,190.815,192.752,198.238,202.392,203.667,205.734,209.888,211.37,213.522,217.305,221.28,223.195,226.68,230.242,231.517,233.57,235.052,238.835,240.987,244.4,246.993,249.145,250.627,254.41,257.595,259.17,261.235,262.717,265.831,271.616,275.471,279.254,282.439,284.591,286.073" svgx:width="0.48,0.48,0.17,0.55,0.5,0.45,0.53,0.48,0.4,0.55,0.34,0.58,0.17,0.55,0.81,0.45,0.53,0.54,0.55,0.46,0.81,0.34,0.17,0.55,0.49,0.53,0.48,0.81,0.48,0.44,0.48,0.29,0.55,0.21,0.81,0.17,0.55,0.81,0.21,0.29,0.3,0.53,0.55,0.77,0.58,0.17,0.55,0.58,0.21,0.3,0.53,0.53,0.55,0.49,0.5,0.17,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.21,0.44,0.81,0.54,0.53,0.45,0.3,0.21,0.44" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">65. Yáñez JA, Wang SWJ, Knemeyer IW, Wirth MA, Alton KB. Intestinal lymphatic</text>
  <text y="268.097" x="71.716,73.867,75.941,79.126,82.909,85.502,89.357,93.14,95.214,97.464,99.494,101.347,105.13,107.30499999999999,109.359,113.213,115.287,118.992,123.042,125.006,128.86,132.273,133.755,135.237,138.422,141.835,143.908,147.022,148.297,150.347,154.501,158.355,161.73,163.67,168.265,170.339,174.044,178.09400000000002,180.053,184.649,188.062,189.544,191.026,194.401,196.381,199.943,203.356,206.541,207.816,209.873,213.286,216.699,220.112,223.525,224.707,228.12,231.533,232.716,236.129,239.541" svgx:width="0.3,0.29,0.45,0.53,0.36,0.54,0.53,0.29,0.3,0.55,0.26,0.53,0.29,0.55,0.54,0.29,0.52,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.17,0.55,0.58,0.54,0.45,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.48,0.21,0.21,0.45,0.55,0.5,0.48,0.45,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">transport for drug delivery. Adv Drug Deliv Rev. 2011;63:923</text>
  <text y="268.097" x="242.929" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="268.097" x="246.5,249.913,253.326" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">42.</text>
  <text y="277.338" x="56.692,60.105,63.518,64.793,71.716,76.09,79.795,83.65,85.802,89.177,91.104,95.258,96.533,98.587,101.851,103.924,107.109,108.684,110.72,115.173,118.735,120.01,122.058,126.511,129.696,131.848,133.999,137.783,141.75799999999998,143.714,146.978,151.131,152.406,154.486,159.081,162.865,165.978,167.46,171.06,173.024,176.586,179.85,181.125,183.172,187.696,190.881,194.664,198.448,201.861,207.646,211.351,212.833,215.426,216.908,220.692,224.475,227.069,228.344,230.396,232.248,236.032,238.105,243.89,247.075,249.227,250.709,254.492,258.276,259.551,261.633,265.487,267.561,271.344,275.199,278.612,280.685,282.837,284.319,287.731" svgx:width="0.48,0.48,0.17,0.55,0.61,0.52,0.54,0.3,0.45,0.55,0.58,0.17,0.55,0.46,0.29,0.45,0.21,0.55,0.63,0.5,0.17,0.55,0.63,0.45,0.3,0.3,0.53,0.53,0.55,0.46,0.58,0.17,0.55,0.64,0.53,0.44,0.21,0.48,0.55,0.5,0.46,0.17,0.55,0.63,0.45,0.53,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.36,0.17,0.55,0.26,0.53,0.29,0.81,0.45,0.3,0.21,0.53,0.53,0.17,0.55,0.54,0.29,0.53,0.54,0.48,0.29,0.3,0.21,0.48,0.36" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">66. Gupta A, Eral HB, Hatton TA, Doyle PS. Nanoemulsions: formation, properties</text>
  <text y="286.352" x="71.716,74.901,78.684,82.734,84.642,87.827,91.681,95.536,97.018,98.5,101.613,104.798,106.95,108.432,112.215,115.998,118.592,119.867,121.945,125.208,128.991,130.844,133.094,135.154,140.64,143.825,145.976,148.128,151.541,153.614,154.889,156.923,160.336,163.749,167.162,170.574,171.757,175.17,178.583,179.766,183.178,186.591,190.004" svgx:width="0.45,0.53,0.54,0.55,0.45,0.54,0.54,0.21,0.21,0.44,0.45,0.3,0.21,0.53,0.53,0.36,0.17,0.55,0.46,0.53,0.26,0.3,0.55,0.77,0.45,0.3,0.3,0.48,0.29,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and applications. Soft Matter. 2016;12:2826</text>
  <text y="286.352" x="193.435" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="286.352" x="197.007,200.42,203.833" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">41.</text>
  <text y="295.593" x="56.691,60.104,63.517,64.792,71.715,73.197,78.313,81.498,85.281,88.466,92.32,95.695,97.623,101.107,102.382,104.426,107.91,111.615,114.209,117.992,119.474,123.329,124.811,127.774,129.349,131.468,134.731,136.006,138.044,143.53,145.012,148.126,151.311,154.125,157.31,160.274,161.849,163.896,169.382,170.657,172.74,176.224,179.409,182.373,185.785,191.571,193.146,195.19,200.676,201.951,203.977,208.572,210.054,212.648,216.502,220.286,222.879,224.361,226.513,227.995,231.778,235.753,237.765,241.548,243.498,245.532,247.014,248.496,252.35,253.832,257.687,259.76,263.615,266.8,269.393,272.806" svgx:width="0.48,0.48,0.17,0.55,0.21,0.72,0.45,0.53,0.45,0.54,0.45,0.55,0.49,0.17,0.55,0.49,0.52,0.36,0.53,0.21,0.54,0.21,0.42,0.21,0.55,0.46,0.17,0.55,0.77,0.21,0.44,0.45,0.4,0.45,0.42,0.21,0.55,0.77,0.17,0.55,0.49,0.45,0.42,0.48,0.81,0.21,0.55,0.77,0.17,0.55,0.64,0.21,0.36,0.54,0.53,0.36,0.21,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.21,0.21,0.54,0.21,0.54,0.29,0.54,0.45,0.36,0.48,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">67. Iwanaga K, Kushibiki T, Miyazaki M, Kakemi M. Disposition of lipid-based</text>
  <text y="304.55" x="71.715,73.568,77.351,79.424,85.21,88.915,90.397,93.581,95.733,97.215,100.998,104.973,106.921,108.403,112.378,114.348,116.499,120.283,123.883,125.799,127.281,131.065,133.216,136.629,139.223,141.374,142.856,146.64,149.825,151.39999999999998,153.465,155.616,157.69,160.875,163.988,166.238,168.261,171.446,173.298,175.151,178.564,181.677,183.829,186.529,188.613,190.765,194.548,198.148,200.065,203.25,207.105,209.698,213.481,215.555,219.409,221.561,223.043,226.826,230.801,232.776,236.56,238.51,240.543,244.398,248.181,251.964,254.038,255.52,258.82,260.782,265.898,269.083,271.234,274.647,276.721" svgx:width="0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.55,0.21,0.53,0.55,0.3,0.53,0.48,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.3,0.29,0.45,0.44,0.3,0.55,0.45,0.26,0.26,0.48,0.44,0.3,0.36,0.55,0.3,0.53,0.48,0.55,0.45,0.54,0.36,0.53,0.29,0.54,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.54,0.53,0.53,0.29,0.21,0.44,0.55,0.72,0.45,0.3,0.48,0.29,0.29" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">formulation in the intestinal tract affects the absorption of poorly water-</text>
  <text y="313.564" x="71.715,74.309,78.092,79.574,83.279,87.133,88.615,92.21499999999999,94.165,98.019,100.093,103.798,107.652,110.246,111.521,113.553,117.116,118.598,122.381,123.956,126.025,129.588,133.371,136.556,138.629,144.70399999999998,146.548,150.11,153.815,155.297,156.779,158.054,160.097,163.51,166.923,170.336,173.749,174.931,178.344,181.757,182.94,186.353,189.765" svgx:width="0.36,0.53,0.21,0.52,0.54,0.21,0.48,0.55,0.54,0.29,0.52,0.54,0.36,0.17,0.55,0.5,0.21,0.53,0.21,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.5,0.52,0.21,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">soluble drugs. Biol Pharm Bull. 2006;29:508</text>
  <text y="313.564" x="193.208" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="313.564" x="196.78,200.193,203.605" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">12.</text>
  <text y="322.805" x="56.691,60.104,63.517,64.792,71.715,73.197,78.313,81.498,85.281,88.466,92.32,95.695,97.623,101.107,102.382,104.426,107.91,111.095,116.211,119.396,123.25,126.435,128.587,131.962,133.962,137.525,138.8,140.879,146.365,147.847,150.96,154.145,156.959,160.144,163.108,164.683,166.73,172.216,173.491,175.517,179.001,182.186,185.15,188.563,194.348,195.923,198.024,203.51,204.785,206.811,211.556,215.261,218.446,222.229,224.381,225.863,228.015,231.199,233.351,234.833,238.018,241.618,243.604,246.789,250.572,253.757,255.239,258.352,260.946,262.428,265.128,267.187,270.971,272.921,274.954,277.106,280.889" svgx:width="0.48,0.48,0.17,0.55,0.21,0.72,0.45,0.53,0.45,0.54,0.45,0.55,0.49,0.17,0.55,0.49,0.45,0.72,0.45,0.54,0.45,0.3,0.45,0.55,0.5,0.17,0.55,0.77,0.21,0.44,0.45,0.4,0.45,0.42,0.21,0.55,0.77,0.17,0.55,0.49,0.45,0.42,0.48,0.81,0.21,0.55,0.77,0.17,0.55,0.67,0.52,0.45,0.53,0.3,0.21,0.3,0.45,0.3,0.21,0.45,0.48,0.55,0.45,0.53,0.45,0.21,0.44,0.36,0.21,0.36,0.55,0.53,0.26,0.55,0.3,0.53,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">68. Iwanaga K, Kawabata Y, Miyazaki M, Kakemi M. Quantitative analysis of the</text>
  <text y="331.819" x="71.715,75.128,76.98,78.833,82.246,85.359,87.609,89.63,93.413,95.363,97.397,99.548,101.622,103.104,106.958,108.44,111.554,114.667,118.08,120.154,121.636,125.49,129.09,131.072,134.257,135.739,138.703,141.816,143.298,145.372,148.485,152.268,155.453,156.935,160.91,162.876,164.358,167.771,171.554,175.409,177.56,181.535,183.512,187.295,191.26999999999998,193.206,195.358,199.141,202.74099999999999,204.658,208.512,211.697,213.771,215.922,217.404,219.556,221.038,224.821,228.605,230.087,233.87,237.92000000000002,239.92,243.704,245.654,247.687,251.471,252.953,256.807,260.59,262.072" svgx:width="0.48,0.26,0.26,0.48,0.44,0.3,0.55,0.53,0.26,0.55,0.3,0.29,0.21,0.54,0.21,0.44,0.44,0.48,0.29,0.21,0.54,0.48,0.55,0.45,0.21,0.42,0.44,0.21,0.29,0.44,0.53,0.45,0.21,0.53,0.55,0.21,0.48,0.53,0.54,0.3,0.53,0.55,0.53,0.53,0.55,0.3,0.53,0.48,0.55,0.54,0.45,0.29,0.3,0.21,0.3,0.21,0.53,0.53,0.21,0.53,0.54,0.55,0.53,0.26,0.55,0.53,0.21,0.54,0.53,0.21,0.44" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">effect of triglyceride alkyl-chain length on the partitioning of highly</text>
  <text y="340.833" x="71.715,73.197,74.679,78.534,82.317,86.171,89.955,91.437,92.919,94.401,97.701,99.664,102.777,106.561,112.346,116.201,119.984,123.689,127.472,131.327,134.027,136.06,138.212,142.18699999999998,144.11,146.262,150.045,153.64499999999998,155.619,161.405,164.818,167.411,170.824,174.607,176.759,180.172,182.245,183.727,187.02700000000002,189.011,190.493,193.606,199.392,203.246,207.221,209.137,210.619,214.594,216.564,218.046,221.829,223.981,227.393,229.987,232.139,233.621,237.404,240.589,242.164,244.229,247.342,250.755,252.237,253.719,256.313,257.58799999999997,259.649,263.803,265.876,268.99" svgx:width="0.21,0.21,0.54,0.53,0.54,0.53,0.21,0.21,0.21,0.44,0.55,0.44,0.53,0.81,0.54,0.53,0.52,0.53,0.54,0.36,0.55,0.3,0.53,0.55,0.3,0.53,0.48,0.55,0.81,0.48,0.36,0.48,0.53,0.3,0.48,0.29,0.21,0.44,0.55,0.21,0.44,0.81,0.54,0.53,0.55,0.21,0.53,0.55,0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.44,0.48,0.21,0.21,0.36,0.17,0.55,0.58,0.29,0.44,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">lipophilic compounds to the mesenteric lymph in intestinal cells. Arch</text>
  <text y="349.847" x="71.715,75.277,79.061,82.246,84.319,90.394,92.238,95.8,99.213,101.806,103.081,105.107,108.519,111.932,115.345,118.758,119.941,123.353,126.766,127.949,131.362,134.775" svgx:width="0.5,0.53,0.45,0.29,0.81,0.55,0.5,0.48,0.36,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Pharm Res. 2014;37:937</text>
  <text y="349.847" x="138.216" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="349.847" x="141.788,145.201,148.613" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">46.</text>
  <text y="359.088" x="56.691,60.104,63.517,64.792,71.715,75.199,78.384,81.198,84.903,88.687,92.47,94.543,96.11800000000001,98.19,99.672,100.947,102.952,106.514,110.298,111.78,114.893,118.677,120.25200000000001,122.34,126.793,128.068,130.107,135.593,138.778,141.742,145.525,147.677,151.652,153.577,159.063,160.338,162.421,167.908,171.092,173.686,176.871,181.986,185.96099999999998,187.933,191.417,192.692,194.736,197.999,201.782,205.566,208.75,212.534,215.647,217.129,220.913,224.96300000000002,226.937,232.722,236.135,239.249,243.032,246.217,250.0,251.482,254.075,261.972,265.755" svgx:width="0.48,0.48,0.17,0.55,0.49,0.45,0.4,0.52,0.53,0.53,0.29,0.21,0.55,0.21,0.17,0.55,0.5,0.53,0.21,0.44,0.53,0.21,0.55,0.63,0.17,0.55,0.77,0.45,0.42,0.53,0.3,0.53,0.55,0.77,0.17,0.55,0.77,0.45,0.36,0.45,0.72,0.53,0.55,0.49,0.17,0.55,0.46,0.53,0.53,0.45,0.53,0.44,0.21,0.53,0.54,0.55,0.81,0.48,0.44,0.53,0.45,0.53,0.21,0.36,0.81,0.53,0.26" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">69. Kazunori I, Yoichi H, Makoto M, Masawo K. Enhancing mechanismof</text>
  <text y="368.102" x="71.715,73.197,76.98,79.132,82.545,85.138,87.29,88.772,92.555,95.74,97.315,99.324,102.509,106.363,108.957,112.74,114.814,118.668,120.82,122.302,126.085,130.06,132.035,135.818,137.768,139.802,143.585,145.067,148.922,152.705,154.187,157.48700000000002,159.474,160.956,162.438,166.292,170.076,173.93,177.714,179.196,180.678,182.16,185.46,187.423,190.536,194.32,200.105,203.96,207.743,211.448,215.231,219.086,221.786,223.819,227.524,230.117,231.599,235.383,239.43300000000002,241.393,247.179,248.661,251.774,253.847,257.631,261.044,266.829,270.534,272.016,274.609,276.091,279.875" svgx:width="0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.45,0.54,0.36,0.53,0.29,0.54,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.53,0.21,0.54,0.53,0.21,0.44,0.55,0.21,0.21,0.54,0.53,0.54,0.53,0.21,0.21,0.21,0.44,0.55,0.44,0.53,0.81,0.54,0.53,0.52,0.53,0.54,0.36,0.55,0.52,0.36,0.21,0.53,0.54,0.55,0.81,0.21,0.44,0.29,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">intestinal absorption of highly lipophilic compounds using microemulsion</text>
  <text y="368.102" x="285.845" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="377.059" x="71.715,75.57,79.275,82.459,86.243,88.394,89.876,92.028,95.213,97.365,98.847,102.031,105.631,107.601,110.786,114.569,117.754,119.236,122.35,124.943,126.425,129.125,131.184,134.968,136.91799999999998,138.951,141.103,144.886,148.486,150.403,154.258,157.443,159.516,161.668,163.15,165.301,166.783,170.567,174.35,175.832,179.615,183.66500000000002,185.666,187.817,191.792,193.716,195.868,199.651,203.251,205.225,211.01,214.423,217.017,220.43,224.213,226.365,229.777,231.851,233.333,236.633,238.56,240.042,243.155,248.941,252.795,256.77,258.742,260.224" svgx:width="0.54,0.52,0.45,0.53,0.3,0.21,0.3,0.45,0.3,0.21,0.45,0.48,0.55,0.45,0.53,0.45,0.21,0.44,0.36,0.21,0.36,0.55,0.53,0.26,0.55,0.3,0.53,0.48,0.55,0.54,0.45,0.29,0.3,0.21,0.3,0.21,0.53,0.53,0.21,0.53,0.54,0.55,0.3,0.53,0.55,0.3,0.53,0.48,0.55,0.81,0.48,0.36,0.48,0.53,0.3,0.48,0.29,0.21,0.44,0.55,0.21,0.44,0.81,0.54,0.53,0.55,0.21,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">quantitative analysis of the partitioning to the mesenteric lymph in</text>
  <text y="386.073" x="71.715,73.197,76.98,79.132,82.545,85.138,87.29,88.772,92.555,95.74,97.315,99.324,102.438,105.85,107.332,108.814,111.408,112.683,114.744,118.898,121.492,122.974,126.159,130.13400000000001,132.092,134.64200000000002,136.684,140.247,144.03,147.215,149.288,155.363,157.207,160.47,163.584,165.065,166.34,168.432,171.845,175.258,178.67,182.083,183.266,186.679,190.092,191.274,194.687,198.1" svgx:width="0.21,0.53,0.3,0.48,0.36,0.3,0.21,0.53,0.45,0.21,0.55,0.44,0.48,0.21,0.21,0.36,0.17,0.55,0.58,0.36,0.21,0.45,0.53,0.55,0.34,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.46,0.44,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">intestinal cells. Asian J Pharm Sci. 2015;10:186</text>
  <text y="386.073" x="201.485" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="386.073" x="205.057,208.47,211.882" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">93.</text>
  <text y="395.314" x="56.691,60.104,63.516,64.791,71.714,74.978,78.162,81.126,82.608,86.392,90.36699999999999,92.293,95.556,96.831,98.869,102.354,106.137,109.92,111.402,113.996,117.779,119.354,121.433,124.917,126.19200000000001,128.235,131.499,134.683,137.647,140.832,143.796,147.501,149.575,152.95,154.937,158.5,159.775,161.797,166.25,169.435,172.029,175.812,177.294,181.149,184.524,186.515,192.001,193.276,195.302,198.487,202.27,206.054,210.104,212.083,215.196,216.678,218.752,221.865,225.57,227.052,230.237,232.389,233.871,237.654,241.704,243.66,247.073,252.859,256.563,258.045,260.639,262.121,265.904,269.879,271.836,274.95,278.135,280.208,282.281,283.763,287.176" svgx:width="0.48,0.48,0.17,0.55,0.46,0.45,0.42,0.21,0.53,0.53,0.55,0.46,0.17,0.55,0.49,0.53,0.53,0.21,0.36,0.53,0.21,0.55,0.49,0.17,0.55,0.46,0.45,0.42,0.45,0.42,0.52,0.29,0.45,0.55,0.5,0.17,0.55,0.63,0.45,0.36,0.53,0.21,0.54,0.45,0.55,0.77,0.17,0.55,0.45,0.53,0.53,0.54,0.55,0.44,0.21,0.29,0.44,0.52,0.21,0.45,0.3,0.21,0.53,0.54,0.55,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.55,0.44,0.45,0.29,0.29,0.21,0.48,0.29" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">70. Takino T, Konishi K, Takakura Y, Hashida M. Long circulating emulsion carrier</text>
  <text y="404.328" x="71.714,74.308,77.421,80.015,82.167,85.579,91.365,94.065,96.091,97.944,101.727,103.902,105.956,109.739,111.221,115.076,118.859,120.341,123.64099999999999,125.571,127.053,128.535,132.39,136.173,140.028,143.811,145.293,146.775,148.257,151.55700000000002,153.52,157.375,159.448,163.153,167.008,169.601,170.876,172.966,176.528,178.01,181.793,183.368,185.381,188.944,192.727,195.912,197.985,204.06,205.96,209.523,213.228,214.71,216.192,217.467,219.51,222.923,226.335,229.748,233.161,234.344,237.757,241.169,242.352,245.765,249.178" svgx:width="0.36,0.44,0.36,0.3,0.48,0.81,0.36,0.55,0.26,0.53,0.29,0.55,0.53,0.21,0.54,0.53,0.21,0.44,0.55,0.21,0.21,0.54,0.53,0.54,0.53,0.21,0.21,0.21,0.44,0.55,0.54,0.29,0.52,0.54,0.36,0.17,0.55,0.5,0.21,0.53,0.21,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.5,0.52,0.21,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">systems for highly lipophilic drugs. Biol Pharm Bull. 1994;17:121</text>
  <text y="404.328" x="252.622" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="404.328" x="256.137,259.549" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">5.</text>
  <text y="413.569" x="56.691,60.104,63.516,64.791,71.714,75.868,79.651,85.437,88.622,92.672,94.618,97.062,98.337,100.401,105.887,107.369,109.544,111.569,114.832,118.395,119.67,121.717,125.201,128.984,132.768,134.25,135.825,137.874,141.358,142.633,144.677,148.681,152.464,156.169,158.321,160.473,163.658,167.441,169.016,171.095,174.579,175.854,177.898,183.384,184.866,187.46,191.243,193.316,196.691,198.647,202.801,206.285,207.56,209.589,213.151,216.336,220.12,223.974,227.349,229.318,233.472,236.956,238.231,240.316,244.47,250.255,251.737,255.712,257.664,260.927,262.202,264.24,267.503,271.286,272.768,274.25" svgx:width="0.48,0.48,0.17,0.55,0.58,0.53,0.81,0.45,0.54,0.55,0.34,0.17,0.55,0.77,0.21,0.29,0.55,0.46,0.5,0.17,0.55,0.49,0.53,0.53,0.21,0.21,0.55,0.49,0.17,0.55,0.56,0.53,0.52,0.3,0.3,0.45,0.53,0.21,0.55,0.49,0.17,0.55,0.77,0.21,0.36,0.53,0.29,0.45,0.55,0.58,0.49,0.17,0.55,0.5,0.45,0.53,0.54,0.45,0.55,0.58,0.49,0.17,0.55,0.58,0.81,0.21,0.53,0.55,0.46,0.17,0.55,0.46,0.53,0.21,0.21,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">71. Ahmad J, Mir SR, Kohli K, Chuttani K, Mishra AK, Panda AK, Amin S. Solid</text>
  <text y="422.583" x="71.714,75.498,78.682,82.466,86.249,89.662,95.447,99.152,100.634,103.228,104.71,108.493,112.46799999999999,114.403,118.258,120.331,123.744,126.857,130.641,134.424,137.538,140.951,144.734,146.886,148.959,152.144,154.295,157.89499999999998,159.87,161.722,165.506,167.681,169.734,173.518,175.591,178.776,180.351,182.377,186.231,189.644,191.126,192.608,195.793,199.206,201.279,204.579,206.584,210.368,212.31799999999998,214.351,218.206,221.391,224.504,225.986,227.468,229.62,232.805,235.847,239.26,240.742,242.017,244.058,245.91,249.694,251.767,257.552,261.257,262.739,265.924,268.076,269.558,273.341" svgx:width="0.53,0.45,0.53,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.55,0.54,0.29,0.48,0.44,0.53,0.53,0.44,0.48,0.53,0.3,0.29,0.45,0.3,0.48,0.55,0.26,0.53,0.29,0.55,0.53,0.29,0.45,0.21,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.53,0.26,0.55,0.54,0.45,0.44,0.21,0.21,0.3,0.45,0.43,0.48,0.21,0.17,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">nanoemulsion preconcentrate for oral delivery of paclitaxel: formulation</text>
  <text y="431.597" x="71.714,75.569,78.982,81.575,83.057,86.912,90.695,91.97,93.994,97.848,99.33,103.114,106.968,108.45,111.044,113.195,115.269,116.751,120.605,124.31,126.462,127.944,131.727,135.511,136.786,138.894,142.078,145.862,149.912,151.82,154.413,157.527,159.009,162.792,164.944,166.426,170.28,172.354,175.538,179.393,183.176,186.476,188.499,189.981,195.767,198.951,202.806,204.288,208.071,211.926,213.201,215.258,218.82,220.302,224.085,229.871,233.284,237.334,239.239,242.801,246.214,248.914,250.974,252.456,256.239,258.391,259.666,261.745,265.158,268.571,271.984,275.397,276.579,279.992,283.405" svgx:width="0.54,0.48,0.36,0.21,0.54,0.53,0.17,0.55,0.54,0.21,0.53,0.54,0.21,0.36,0.3,0.29,0.21,0.54,0.52,0.3,0.21,0.53,0.53,0.17,0.55,0.45,0.53,0.54,0.55,0.36,0.44,0.21,0.53,0.3,0.21,0.54,0.29,0.45,0.54,0.53,0.44,0.55,0.21,0.81,0.45,0.54,0.21,0.53,0.54,0.17,0.55,0.5,0.21,0.53,0.81,0.48,0.54,0.55,0.5,0.48,0.36,0.55,0.21,0.53,0.3,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">design, biodistribution, and scintigraphy imaging. Biomed Res Int. 2014;98:</text>
  <text y="440.554" x="71.714,75.127" svgx:width="0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">47</text>
  <text y="440.554" x="78.517" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="440.554" x="82.089,85.502,88.915" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">56.</text>
  <text y="449.795" x="56.69,60.103,63.516,64.791,71.714,75.198,76.68,79.273,83.056,84.538,86.69,90.065,92.01,95.494,96.769,98.812,100.294,104.149,107.334,109.407,112.592,115.556,117.131,119.222,122.706,123.98100000000001,126.025,127.507,129.658,132.843,135.807,139.512,141.585,144.96,146.944,150.207,151.482,153.52,157.083,160.268,166.053,169.238,171.831,175.016,177.98,179.55499999999998,181.582,185.145,186.42000000000002,188.499,193.023,194.505,197.098,200.882,202.364,205.328,208.512,210.664,214.039,215.994,220.519,221.794,223.874,227.437,230.622,236.407,239.592,245.377,249.161,251.312,255.287,257.209,260.693,261.96799999999996,264.012,267.275,271.058,272.54,278.326,279.808,282.622" svgx:width="0.48,0.48,0.17,0.55,0.49,0.21,0.36,0.53,0.21,0.3,0.45,0.55,0.49,0.17,0.55,0.21,0.54,0.45,0.29,0.45,0.42,0.21,0.55,0.49,0.17,0.55,0.21,0.3,0.45,0.42,0.52,0.29,0.45,0.55,0.46,0.17,0.55,0.5,0.45,0.81,0.45,0.36,0.45,0.42,0.21,0.55,0.5,0.17,0.55,0.63,0.21,0.36,0.53,0.21,0.42,0.45,0.3,0.45,0.55,0.63,0.17,0.55,0.5,0.45,0.81,0.45,0.81,0.53,0.3,0.53,0.55,0.49,0.17,0.55,0.46,0.53,0.21,0.81,0.21,0.4,0.52" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">72. Kishita K, Ibaraki K, Itakura S, Yamasaki Y, Nishikata N, Yamamoto K, Shimizu</text>
  <text y="458.809" x="71.714,77.2,78.47500000000001,80.501,85.025,86.507,89.101,92.884,94.366,97.479,100.664,106.45,109.825,111.795,115.279,116.554,118.598,122.16,125.345,131.13,134.315,136.909,140.093,143.057,144.63199999999998,146.717,152.203,153.478,155.504,159.066,161.14,164.552,168.407,171.592,173.665,176.85,179.002,180.484,184.267,188.242,190.256,194.039,195.98899999999998,198.022,201.136,204.919,208.703,210.185,213.89,217.744,220.929,223.081,226.494,230.544,232.491,233.973,235.455,239.239,243.022,244.504,247.917,249.399,252.699,254.658,257.842,260.956,262.438" svgx:width="0.77,0.17,0.55,0.63,0.21,0.36,0.53,0.21,0.44,0.45,0.81,0.45,0.55,0.49,0.17,0.55,0.5,0.45,0.81,0.45,0.36,0.45,0.42,0.21,0.55,0.77,0.17,0.55,0.5,0.29,0.48,0.54,0.45,0.29,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.44,0.53,0.53,0.21,0.52,0.54,0.45,0.3,0.48,0.54,0.55,0.21,0.21,0.53,0.53,0.21,0.48,0.21,0.44,0.55,0.45,0.44,0.21,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">M, Nishiyama K, Yamasaki M. Preparation of conjugated linoleic acid</text>
  <text y="467.823" x="71.714,77.499,78.981,82.095,84.168,87.951,91.364,97.149,100.854,102.336,104.93,106.412,110.195,113.979,116.679,118.711,121.896,125.679,129.729,131.693,133.845,137.628,141.041,142.523,144.698,146.717,150.571,152.053,155.837,159.691,161.173,163.767,165.918,167.992,169.474,173.328,177.033,179.185,180.667,184.45,188.234,189.50900000000001,191.616,194.16600000000003,196.152,200.897,202.379,205.792,209.767,211.742,215.005,218.119,219.601,220.876,222.91,226.323,229.736,233.149,236.562,237.744,241.157,244.57,245.753,249.166,252.579" svgx:width="0.81,0.21,0.44,0.29,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.36,0.55,0.45,0.53,0.54,0.55,0.3,0.53,0.48,0.21,0.29,0.55,0.54,0.21,0.53,0.54,0.21,0.36,0.3,0.29,0.21,0.54,0.52,0.3,0.21,0.53,0.53,0.17,0.55,0.34,0.55,0.67,0.21,0.48,0.53,0.55,0.46,0.44,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">microemulsions and their biodistribution. J Oleo Sci. 2016;65:949</text>
  <text y="467.823" x="256.023" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="467.823" x="259.594,263.007,266.42" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">54.</text>
  <text y="477.063" x="56.69,60.103,63.516,64.791,71.714,75.276,78.461,80.534,83.68400000000001,85.603,91.089,93.533,94.808,96.884,100.447,103.86,107.835,109.753,113.017,114.292,116.387,119.572,122.984,126.58399999999999,128.519,132.081,134.525" svgx:width="0.48,0.48,0.17,0.55,0.5,0.45,0.29,0.42,0.55,0.77,0.34,0.17,0.55,0.5,0.48,0.53,0.55,0.46,0.17,0.55,0.45,0.48,0.48,0.55,0.5,0.34,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">73. Park MJ, Ren S, Lee BJ.</text>
  <text y="477.063" x="137.875,139.278,143.10299999999998,145.018,147.982,149.386,151.459,153.461" svgx:width="0.2,0.51,0.55,0.42,0.2,0.29,0.28,0.5" style="fill:rgb(19,20,19);font-family:GdsllxAdvTT1b53b5fb.I;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">In vitro</text>
  <text y="477.063" x="159.191,162.376,166.159" svgx:width="0.45,0.53,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and</text>
  <text y="477.063" x="172.174,173.578,177.403,179.374,182.338,183.741,186.705" svgx:width="0.2,0.51,0.55,0.42,0.2,0.42,0.5" style="fill:rgb(19,20,19);font-family:GdsllxAdvTT1b53b5fb.I;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">in vivo</text>
  <text y="477.063" x="192.414,195.527,199.311,205.096,208.951,212.135,214.209,217.394,219.545,221.027,224.212,227.81199999999998,229.774,232.367,234.519,238.224,242.078,245.37800000000001,247.348,251.131,253.081,255.115,256.597,258.749,260.822,264.007,267.12,270.904,274.687,277.872,280.686,284.47,285.952" svgx:width="0.44,0.53,0.81,0.54,0.45,0.29,0.45,0.3,0.21,0.45,0.48,0.55,0.36,0.3,0.52,0.54,0.44,0.55,0.53,0.26,0.55,0.21,0.3,0.29,0.45,0.44,0.53,0.53,0.45,0.4,0.53,0.21,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">comparative study of itraconazole</text>
  <text y="486.078" x="71.714,75.569,77.051,80.834,84.019,87.204,90.389,91.871,93.353,96.537,100.392,101.874,103.356,104.838,106.99,110.28999999999999,112.249,117.364,121.148,124.56,128.535,130.503,132.356,136.139,138.212,143.998,147.703,149.185,152.37,154.521,157.934,161.984,163.951,165.433,169.408,171.321,175.104,176.586,180.441,184.224,185.706,189.006,190.993,193.586,197.37,198.852,202.557,206.411,207.893,211.493,213.443,216.036,219.449,220.931,222.784,224.857,228.27,234.055,237.76,239.242,241.836,243.318,245.17,248.284,249.766,253.549,257.599,259.59,262.184,265.297,267.891,270.042,273.455" svgx:width="0.54,0.21,0.53,0.45,0.45,0.45,0.21,0.21,0.45,0.54,0.21,0.21,0.21,0.3,0.44,0.55,0.72,0.53,0.48,0.53,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.48,0.54,0.55,0.21,0.53,0.55,0.53,0.21,0.54,0.53,0.21,0.44,0.55,0.36,0.53,0.21,0.52,0.54,0.21,0.48,0.55,0.36,0.48,0.21,0.26,0.29,0.48,0.81,0.52,0.21,0.36,0.21,0.26,0.44,0.21,0.53,0.54,0.55,0.36,0.44,0.36,0.3,0.48,0.81" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">bioavailability when formulated in highly soluble self-emulsifying system</text>
  <text y="495.092" x="71.714,74.899,78.682,82.732,84.64,86.122,90.097,92.067,94.661,98.444,99.926,101.408,105.458,107.431,111.285,112.767,115.361,119.215,122.628,124.701,127.295,128.777,132.56,136.344,137.619,139.688,143.25,144.732,148.516,152.37,156.154,159.338,161.412,167.487,169.338,173.933,176.006,179.711,183.76100000000002,185.721,190.317,191.799,194.392,198.247,202.03,204.624,205.899,207.945,211.357,214.77,218.183,221.596,222.779,226.191,229.604,230.787,234.2,237.613" svgx:width="0.45,0.53,0.54,0.55,0.21,0.53,0.55,0.36,0.53,0.21,0.21,0.54,0.55,0.54,0.21,0.36,0.54,0.48,0.29,0.36,0.21,0.53,0.53,0.17,0.55,0.5,0.21,0.53,0.54,0.53,0.45,0.29,0.81,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.21,0.36,0.54,0.53,0.36,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and in solid dispersion. Biopharm Drug Dispos. 2007;28:199</text>
  <text y="495.092" x="241.057" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="495.092" x="244.572,247.984,251.397,254.81" svgx:width="0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">207.</text>
  <text y="504.332" x="56.691,60.104,63.516,64.791,71.714,76.239,80.022,82.095,85.879,89.662,93.637,95.581,99.735,104.48,105.75500000000001,107.77,111.553,115.337,118.749,122.533,126.583,128.576,133.029,137.183,138.458,140.481,143.666,147.449,151.304,154.717,157.417,159.472,162.657,166.22,167.495,169.507,171.951,175.734,179.518,183.301,185.894,189.678,193.461,195.534,199.097,202.51,205.103,207.255,209.328,212.741,216.596,220.571,222.571,226.133,227.40800000000002,229.43,232.915,236.099,239.883,243.666,246.851,250.826,252.787,256.271,257.546,259.59,263.153,266.565,269.978,274.028,275.974,279.536" svgx:width="0.48,0.48,0.17,0.55,0.63,0.53,0.29,0.53,0.53,0.53,0.55,0.58,0.67,0.17,0.55,0.53,0.53,0.48,0.53,0.54,0.55,0.63,0.58,0.17,0.55,0.45,0.53,0.54,0.48,0.36,0.55,0.45,0.5,0.17,0.55,0.34,0.53,0.53,0.53,0.36,0.53,0.53,0.29,0.5,0.48,0.36,0.3,0.29,0.48,0.54,0.53,0.55,0.5,0.17,0.55,0.49,0.45,0.53,0.53,0.45,0.53,0.55,0.49,0.17,0.55,0.5,0.48,0.48,0.54,0.55,0.5,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">74. Nornoo AO, Zheng HA, Lopes LB, Johnson-Restrepo B, Kannan K, Reed R.</text>
  <text y="513.346" x="71.714,76.459,78.533,81.718,83.293,85.32,91.105,92.587,95.701,97.774,101.558,104.97,110.756,114.461,115.943,118.536,120.018,123.802,127.585,130.285,132.374,136.158,138.10799999999998,140.141,143.996,147.181,150.294,151.776,153.258,155.41,158.595,161.637,165.05,166.532" svgx:width="0.67,0.29,0.45,0.21,0.55,0.81,0.21,0.44,0.29,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.36,0.55,0.53,0.26,0.55,0.54,0.45,0.44,0.21,0.21,0.3,0.45,0.43,0.48,0.21,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Oral microemulsions of paclitaxel:</text>
  <text y="513.346" x="169.85,171.253,175.07799999999997,177.05,179.493,180.897,182.97" svgx:width="0.2,0.51,0.55,0.34,0.2,0.29,0.5" style="fill:rgb(19,20,19);font-family:GdsllxAdvTT1b53b5fb.I;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">In situ</text>
  <text y="513.346" x="188.672,191.857,195.64,199.69,201.654,205.509,209.292,212.477,214.55,220.335,223.52,226.634,230.417,233.381,234.863,238.646,242.059,244.211,245.693,248.99300000000002,250.975,253.569,255.721,259.426,263.28,264.762,268.175,270.768,272.04299999999995,274.106,277.369,281.074,283.249,285.274" svgx:width="0.45,0.53,0.54,0.55,0.54,0.53,0.45,0.29,0.81,0.45,0.44,0.53,0.42,0.21,0.53,0.48,0.3,0.21,0.44,0.55,0.36,0.3,0.52,0.54,0.21,0.48,0.36,0.17,0.55,0.46,0.52,0.29,0.55,0.34" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and pharmacokinetic studies. Eur J</text>
  <text y="522.304" x="71.714,75.276,79.059,82.244,84.318,90.393,92.236,95.799,97.281,101.064,104.918,108.702,111.887,113.96,119.745,121.02000000000001,123.076,126.489,129.902,133.315,136.728,137.91,141.323,144.736,145.919,149.332,152.744" svgx:width="0.5,0.53,0.45,0.29,0.81,0.55,0.5,0.21,0.53,0.54,0.53,0.45,0.29,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Pharm Biopharm. 2009;71:310</text>
  <text y="522.304" x="156.186" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="522.304" x="159.701,163.114" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">7.</text>
  <text y="531.544" x="56.69,60.103,63.516,64.791,71.714,75.289,78.565,82.439,86.408,89.593,93.608,95.183,98.029,101.658,102.933,105.797,109.142,112.374,115.889,119.939,122.692,128.248,132.493,133.768,136.631,141.097,144.972,148.94,152.125,154.383,157.568,161.583,165.438,167.011,170.923,174.298,177.046,180.391,184.045,187.62,188.895,191.759,195.104,200.311,203.815,207.319,211.29399999999998,214.009,217.513,221.113,223.862,227.094,230.969,234.843,237.111,240.387,241.96,245.835,247.408,251.282,255.33200000000002,258.085,259.659,261.141,265.158,266.745" svgx:width="0.48,0.48,0.17,0.55,0.49,0.45,0.53,0.54,0.45,0.54,0.21,0.55,0.5,0.17,0.55,0.46,0.44,0.48,0.54,0.55,0.77,0.58,0.17,0.55,0.61,0.53,0.54,0.45,0.29,0.45,0.54,0.53,0.21,0.53,0.45,0.55,0.46,0.5,0.49,0.17,0.55,0.46,0.72,0.48,0.48,0.53,0.55,0.48,0.48,0.55,0.44,0.53,0.53,0.3,0.45,0.21,0.53,0.21,0.53,0.54,0.55,0.21,0.21,0.54,0.21,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">75. Kandadi P, Syed MA, Goparaboina SVK. Tween 80 containing lipid</text>
  <text y="540.558" x="71.714,75.581,78.85,82.717,86.585,90.082,95.977,99.776,101.342,104.019,105.585,109.453,113.32,116.02,118.876,120.813,124.724,126.899,129.713,133.682,137.179,138.661,140.296,143.585,147.081,149.239,152.53900000000002,155.305,159.16,161.10999999999999,163.979,165.566,169.434,173.402,174.884,178.845,182.03,185.364,186.93,189.10500000000002,191.976,194.212,198.18699999999998,200.959,204.813,207.081,210.266,211.9,215.811,217.086,219.893,224.131,227.363,229.599,232.974,235.722,239.407,243.262,246.531,248.688,254.76299999999998,257.419,260.764,262.33,266.305,269.077,272.723" svgx:width="0.53,0.45,0.53,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.36,0.55,0.26,0.53,0.29,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.53,0.26,0.55,0.21,0.53,0.54,0.21,0.53,0.45,0.45,0.21,0.29,0.55,0.3,0.53,0.55,0.54,0.29,0.45,0.21,0.53,0.17,0.55,0.58,0.44,0.3,0.45,0.55,0.5,0.53,0.45,0.29,0.81,0.55,0.46,0.21,0.53,0.55,0.5,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">nanoemulsions for delivery of indinavir to brain. Acta Pharm Sin B.</text>
  <text y="549.573" x="71.714,75.126,78.687,82.205,85.723,86.971,90.489,91.777,95.19,98.75" svgx:width="0.48,0.48,0.48,0.48,0.17,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2013;3:345</text>
  <text y="549.573" x="102.271" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="549.573" x="105.899,109.414,112.928" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">53.</text>
  <text y="558.813" x="56.689,60.102,63.515,64.79,71.713,77.199,80.384,82.457,85.642,89.425,93.209,96.394,100.369,102.326,105.889,109.893,111.168,113.211,116.474,119.887,121.961,125.074,128.188,131.373,134.523,136.512,140.666,146.152,147.427,149.438,153.0,156.413,160.268,164.122,166.195,169.38,172.565,176.165,178.124,181.387,185.762,187.037,189.122,192.385,194.238,196.09,199.503,202.617,204.768,207.468,209.531,213.315,215.265,217.298,220.412,224.195,227.978,229.46,232.873,235.467,237.618,241.031,243.105,246.888,248.463,250.519,253.633,257.416,261.2,263.351,266.764,270.548,272.798,274.84,278.624" svgx:width="0.48,0.48,0.17,0.55,0.77,0.45,0.29,0.45,0.53,0.53,0.45,0.53,0.55,0.5,0.56,0.17,0.55,0.46,0.48,0.29,0.44,0.44,0.45,0.42,0.55,0.58,0.77,0.17,0.55,0.5,0.48,0.54,0.54,0.29,0.45,0.45,0.48,0.55,0.46,0.61,0.17,0.55,0.46,0.26,0.26,0.48,0.44,0.3,0.36,0.55,0.53,0.26,0.55,0.44,0.53,0.53,0.21,0.48,0.36,0.3,0.48,0.29,0.53,0.21,0.55,0.44,0.53,0.53,0.3,0.48,0.53,0.3,0.55,0.53,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">76. Maranhao RC, Tercyak AM, Redgrave TG. Effects of cholesterol content on</text>
  <text y="567.827" x="71.713,73.865,77.648,81.24799999999999,83.165,88.95,92.363,94.515,97.7,101.554,105.337,106.819,108.301,110.895,116.97,118.824,122.607,124.557,126.648,130.503,132.576,136.359,138.511,141.924,143.406,147.189,149.262,151.115,153.188,156.601,160.201,162.137,165.55,171.335,175.04,176.522,179.116,180.598,184.381,188.356,190.313,196.099,199.882,203.737,207.149,208.631,211.331,213.387,217.17,219.11999999999998,221.153,222.635,224.117,227.972,231.755,235.61,237.683,241.466,243.618,247.031,248.513,252.296,254.89,256.16499999999996,258.23,261.792,263.274,267.058,270.171,273.955,275.437" svgx:width="0.3,0.53,0.48,0.55,0.81,0.48,0.3,0.45,0.54,0.53,0.21,0.21,0.36,0.81,0.55,0.53,0.26,0.55,0.54,0.29,0.53,0.3,0.48,0.21,0.53,0.29,0.26,0.29,0.48,0.48,0.55,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.55,0.81,0.53,0.54,0.48,0.21,0.36,0.55,0.53,0.26,0.55,0.21,0.21,0.54,0.53,0.54,0.29,0.53,0.3,0.48,0.21,0.53,0.36,0.17,0.55,0.5,0.21,0.53,0.44,0.53,0.21,0.81" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">the metabolism of protein-free emulsion models of lipoproteins. Biochim</text>
  <text y="576.841" x="71.713,75.275,76.757,80.541,84.395,88.179,91.292,93.992,96.034,100.188,103.301,105.453,108.638,109.91300000000001,111.964,115.377,118.79,122.203,125.616,126.798,130.211,133.624,137.037,138.22,141.632,145.045" svgx:width="0.5,0.21,0.53,0.54,0.53,0.44,0.36,0.55,0.58,0.44,0.3,0.45,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Biophys Acta. 1986;875:247</text>
  <text y="576.841" x="148.419" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="576.841" x="151.991,155.403,158.816" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">55.</text>
  <text y="586.082" x="56.689,60.102,63.515,64.79,71.713,75.197,78.61,82.464,85.649,87.824,89.854,94.307,95.58200000000001,97.621,101.184,104.967,108.672,110.824,114.008,117.792,121.392,123.359,126.922,128.197,130.219,133.482,137.266,138.747,142.602,146.385,149.57,152.684,156.284,158.281,161.544,162.81900000000002,164.857,168.341,171.526,175.381,178.566,184.641,186.514,190.076,191.351,193.373,197.527,201.382,204.567,207.751,211.535,214.648,218.061,220.761,222.853,224.335,228.31,230.223,234.078,237.861,239.343,242.457,248.242,251.655,253.728,255.21,258.51,260.497,266.283,267.764,270.878,274.291,275.773,277.255,280.668" svgx:width="0.48,0.48,0.17,0.55,0.49,0.48,0.54,0.45,0.29,0.55,0.63,0.17,0.55,0.5,0.53,0.52,0.3,0.45,0.53,0.48,0.55,0.5,0.17,0.55,0.46,0.53,0.21,0.54,0.53,0.45,0.44,0.48,0.55,0.46,0.17,0.55,0.49,0.45,0.54,0.45,0.81,0.55,0.5,0.17,0.55,0.58,0.54,0.45,0.45,0.53,0.44,0.48,0.36,0.55,0.21,0.53,0.55,0.54,0.53,0.21,0.44,0.81,0.48,0.29,0.21,0.44,0.55,0.81,0.21,0.44,0.48,0.21,0.21,0.48,0.36" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">77. Kedar U, Phutane P, Shidhaye S, Kadam V. Advances in polymeric micelles</text>
  <text y="595.096" x="71.713,73.565,77.349,79.524,81.52,85.375,87.448,91.153,95.203,97.167,101.022,104.435,105.917,107.399,110.583,113.996,116.07,119.36999999999999,121.375,124.56,128.343,132.393,134.301,136.453,140.157,145.943,149.726,151.901,153.973,156.124,159.309,161.383,165.237,168.65,170.802,172.284,176.067,179.922,181.197,183.282,187.807,190.992,194.775,198.558,204.344,207.756,211.806,213.726,218.25,221.435,225.218,229.001,231.153,234.566,237.68,241.655,243.602,247.165,248.647,252.43,254.005,256.075,261.561,264.974,268.828,270.10299999999995,272.175,275.588,279.0,282.413,285.826" svgx:width="0.26,0.53,0.29,0.55,0.54,0.29,0.52,0.54,0.55,0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.45,0.53,0.54,0.55,0.3,0.52,0.81,0.53,0.29,0.55,0.3,0.45,0.29,0.54,0.48,0.3,0.21,0.53,0.54,0.17,0.55,0.63,0.45,0.53,0.53,0.81,0.48,0.54,0.55,0.63,0.45,0.53,0.53,0.3,0.48,0.44,0.53,0.55,0.5,0.21,0.53,0.21,0.55,0.77,0.48,0.54,0.17,0.55,0.48,0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">for drug delivery and tumor targeting. Nanomed Nanotech Biol Med. 2010;</text>
  <text y="604.054" x="71.713,75.126,76.308,79.721,83.134" svgx:width="0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">6:714</text>
  <text y="604.054" x="86.51" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="604.054" x="90.082,93.494,96.907" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">29.</text>
  <text y="613.295" x="56.689,60.102,63.515,64.79,71.713,76.308,79.493,82.678,84.16,88.21,90.138,93.401,94.676,96.714,101.31,104.495,107.679,109.161,113.211,115.195,119.57,120.845,122.905,127.28,130.465,132.538,135.83800000000002,137.816,141.0,142.275,144.335,146.779,149.964,155.749,159.162,161.862,163.893,167.456,168.731,170.753,174.316,178.021,179.503,181.576,185.138,188.843,192.256,196.231,198.192,203.977,205.252,207.32,208.802,212.656,214.73,217.914,221.698,223.18,229.255,231.13,235.284,236.559,238.614,242.768,245.361,247.213,250.398,252.573,254.601,257.864" svgx:width="0.48,0.48,0.17,0.55,0.64,0.45,0.45,0.21,0.54,0.55,0.46,0.17,0.55,0.64,0.45,0.45,0.21,0.54,0.55,0.61,0.17,0.55,0.61,0.45,0.29,0.44,0.55,0.45,0.17,0.55,0.34,0.45,0.81,0.48,0.36,0.55,0.5,0.17,0.55,0.5,0.52,0.21,0.29,0.5,0.52,0.48,0.53,0.55,0.81,0.17,0.55,0.21,0.54,0.29,0.45,0.53,0.21,0.81,0.55,0.58,0.17,0.55,0.58,0.36,0.26,0.45,0.29,0.55,0.46,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">78. David F, David G, Gary L, James R, Pui-Yuen W, Ibrahim A, Asfar S.</text>
  <text y="622.309" x="71.713,75.275,79.059,82.243,84.317,90.102,93.287,96.401,100.184,103.148,104.63,108.413,111.826,113.978,115.46,118.573,121.273,123.302,127.085,129.035,131.069,134.444,136.398,140.182,143.595,148.995,150.855,154.638,156.712,159.896,161.47099999999998,163.554,165.406,169.189,171.263,177.048,180.753,182.235,185.42,187.572,189.054,192.837,196.81199999999998,198.759,202.542,204.492,206.526,209.64,212.753,215.867,217.349,221.132,223.725,227.58,231.363,233.437,234.919,238.702,242.302,244.283,245.765,249.73999999999998,251.71,253.192,254.674,257.859,261.272" svgx:width="0.5,0.53,0.45,0.29,0.81,0.45,0.44,0.53,0.42,0.21,0.53,0.48,0.3,0.21,0.44,0.36,0.55,0.53,0.26,0.55,0.45,0.55,0.53,0.48,0.72,0.55,0.53,0.29,0.45,0.21,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.44,0.44,0.44,0.21,0.53,0.36,0.54,0.53,0.29,0.21,0.53,0.48,0.55,0.21,0.53,0.55,0.21,0.21,0.45,0.48,0.29" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Pharmacokinetics of a new oral formulation of cyclosporine in liver</text>
  <text y="631.323" x="71.713,73.865,75.938,79.123,82.906,85.5,89.354,90.836,94.021,97.804,100.054,102.1,104.173,107.586,110.7,112.182,116.036,117.518,120.931,124.714,126.866,129.459,130.734,132.77,136.033,139.816,143.229,145.40400000000002,147.453,152.048,154.122,157.827,161.877,163.836,169.323,173.106,176.889,178.371,180.523,181.798,183.849,187.262,190.675,194.087,197.5,198.683,202.096,205.509,206.691,210.104,213.517" svgx:width="0.3,0.29,0.45,0.53,0.36,0.54,0.21,0.45,0.53,0.3,0.55,0.29,0.48,0.44,0.21,0.54,0.21,0.48,0.53,0.3,0.36,0.17,0.55,0.46,0.53,0.48,0.29,0.55,0.64,0.29,0.52,0.54,0.55,0.77,0.53,0.53,0.21,0.3,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">transplant recipients. Ther Drug Monit. 1995;17:213</text>
  <text y="631.323" x="216.96" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="631.323" x="220.532,223.945" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">6.</text>
  <text y="640.564" x="56.689,60.102,63.515,64.79,71.713,77.498,78.98,82.094,85.058,86.54,88.022,91.805,95.405,97.338,100.601,104.755,106.03,108.109,111.294,114.479,118.262,121.076,124.451,126.421,130.795,136.282,137.55700000000002,139.573,144.098,147.282,151.066,154.849,157.001,160.414,163.527,167.311,171.094,174.877,176.359,180.142,183.997,187.29700000000003,189.292,191.144,194.927,197.102,199.156,204.941,208.725,210.207,213.62,216.733,220.438,221.92,225.105,227.28,229.316,230.798,236.583,239.768,243.622,245.104,248.888,252.93800000000002,254.883,258.068,261.852" svgx:width="0.48,0.48,0.17,0.55,0.81,0.21,0.44,0.42,0.21,0.21,0.53,0.48,0.55,0.46,0.58,0.17,0.55,0.45,0.45,0.53,0.4,0.45,0.55,0.61,0.77,0.17,0.55,0.63,0.45,0.53,0.53,0.3,0.48,0.44,0.53,0.53,0.53,0.21,0.53,0.54,0.44,0.55,0.26,0.53,0.29,0.55,0.81,0.53,0.21,0.48,0.44,0.52,0.21,0.45,0.29,0.55,0.21,0.81,0.45,0.54,0.21,0.53,0.54,0.55,0.45,0.53,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">79. Wickline SA, Lanza GM. Nanotechnology for molecular imaging and</text>
  <text y="649.587" x="71.716,73.868,77.053,79.126,82.981,86.394,88.546,91.958,96.008,97.965,100.116,103.9,107.312,109.386,112.571,116.425,119.539,120.81400000000001,122.852,126.856,128.338,130.411,133.525,137.23,138.712,141.897,144.048,145.53,149.314,153.097,154.372,156.47,159.883,163.296,166.709,170.121,171.304,174.717,178.13,181.543,182.725,186.138,189.551,192.964" svgx:width="0.3,0.45,0.29,0.54,0.48,0.3,0.48,0.54,0.55,0.3,0.53,0.48,0.29,0.45,0.54,0.44,0.17,0.55,0.56,0.21,0.29,0.44,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">targeted therapy. Circulation. 2003;107:1092</text>
  <text y="649.587" x="196.384" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="649.587" x="199.899,203.312" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">5.</text>
  <text y="658.829" x="56.692,60.105,63.518,64.793,71.716,74.979,78.834,84.619,88.402,92.186,96.236,98.19,100.634,101.909,103.917,107.18,109.773,112.367,115.78,119.563,121.715,123.197,126.382,127.95700000000001,130.052,133.906,137.689,139.171,142.285,145.99,149.773,152.367,155.552,157.703,161.408,163.482,166.666,168.818,172.231,176.281,178.239,180.092,183.277,185.428,187.58,190.88000000000002,192.866,196.051,199.165,200.647,204.501,207.201,209.25,212.435,216.218,220.268,222.176,224.328,228.111,231.71099999999998,233.685,237.539,240.724,242.797,244.871,246.353,249.766,251.941,253.98,256.132,260.107,262.087,264.238,268.022,271.622,273.539,277.393,279.466,282.651,284.133,287.917" svgx:width="0.48,0.48,0.17,0.55,0.46,0.54,0.81,0.53,0.53,0.54,0.55,0.34,0.17,0.55,0.46,0.36,0.36,0.48,0.53,0.3,0.21,0.45,0.21,0.55,0.54,0.53,0.21,0.44,0.52,0.53,0.36,0.45,0.3,0.52,0.29,0.45,0.3,0.48,0.54,0.55,0.26,0.45,0.3,0.3,0.44,0.55,0.45,0.44,0.21,0.54,0.36,0.55,0.45,0.53,0.54,0.55,0.3,0.53,0.48,0.55,0.54,0.45,0.29,0.29,0.21,0.48,0.29,0.55,0.3,0.53,0.55,0.3,0.53,0.48,0.55,0.54,0.29,0.45,0.21,0.53,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">80. Edmond J. Essential polyunsaturated fatty acids and the barrier to the brain:</text>
  <text y="667.843" x="71.716,73.868,77.651,81.25099999999999,83.168,86.281,90.065,95.85,99.705,103.488,107.271,110.684,114.467,116.619,119.319,121.378,125.161,127.111,129.145,132.52,134.474,140.259,144.043,147.897,151.31,152.885,154.94,156.792,160.575,162.75,164.804,166.956,169.029,172.214,175.997,178.591,182.445,186.229,188.302,190.454,191.729,193.773,196.323,198.365,203.851,207.635,209.20999999999998,211.234,215.759,219.171,222.876,224.95,228.733,231.326,234.44,235.922,237.197,239.296,242.709,246.122,249.535,252.948,254.13,257.543,260.956,262.139,265.552,268.964" svgx:width="0.3,0.53,0.48,0.55,0.44,0.53,0.81,0.54,0.53,0.53,0.48,0.53,0.3,0.36,0.55,0.53,0.26,0.55,0.45,0.55,0.81,0.53,0.54,0.48,0.21,0.55,0.26,0.53,0.29,0.55,0.3,0.29,0.45,0.53,0.36,0.54,0.53,0.29,0.3,0.17,0.55,0.34,0.55,0.77,0.53,0.21,0.55,0.63,0.48,0.52,0.29,0.53,0.36,0.44,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">the components of a model for transport. J Mol Neurosci. 2001;16:181</text>
  <text y="667.843" x="272.352" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="667.843" x="275.924,279.337,282.75" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">93.</text>
  <text y="676.801" x="71.716,75.57,77.052,79.646,82.759,86.464,89.058,91.651,93.133,96.917,100.892,102.839,106.252,109.665" svgx:width="0.54,0.21,0.36,0.44,0.52,0.36,0.36,0.21,0.53,0.53,0.55,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">discussion 215</text>
  <text y="676.801" x="113.101" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="676.801" x="116.616,120.029,123.442" svgx:width="0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">221</text>
  <text y="686.098" x="56.692,60.104,63.517,64.792,71.715,75.869,81.654,85.509,87.582,91.287,95.07,97.664,99.239,101.251,105.405,106.68,108.735,113.109,116.522,118.004,121.859,125.272,127.345,128.827,132.61,135.985,137.987,141.251,142.526,144.564,148.048,151.831,155.016,156.498,159.683,163.466,166.059,169.023,172.323,174.27,178.424,179.699,181.753,185.017,188.201,191.985,194.578,197.542,199.117,201.199,204.462,205.737,207.775,211.038,214.822,218.234,219.716,222.31,225.723,229.698,231.642,235.796,237.071,239.125,242.609,244.683,248.096,251.8,253.952,257.365,259.54,261.575,264.019" svgx:width="0.48,0.48,0.17,0.55,0.58,0.81,0.54,0.29,0.52,0.53,0.36,0.21,0.55,0.58,0.17,0.55,0.61,0.48,0.21,0.54,0.48,0.29,0.21,0.53,0.45,0.55,0.46,0.17,0.55,0.49,0.53,0.45,0.21,0.45,0.53,0.36,0.42,0.44,0.55,0.58,0.17,0.55,0.46,0.45,0.53,0.36,0.42,0.21,0.55,0.46,0.17,0.55,0.46,0.53,0.48,0.21,0.36,0.48,0.53,0.55,0.58,0.17,0.55,0.49,0.29,0.48,0.52,0.3,0.48,0.29,0.55,0.34,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">81. Ambruosi A, Gelperina S, Khalansky A, Tanski S, Theisen A, Kreuter J.</text>
  <text y="695.056" x="71.715,73.197,76.98,78.833,80.315,84.02,87.433,91.216,94.33,97.92999999999999,99.89,103.674,105.62400000000001,107.657,110.251,113.956,116.029,117.882,121.066,124.18,126.332,129.517,133.3,135.452,138.045,139.32,141.389,145.243,149.027,150.509,153.622,159.408,162.82,164.995,167.013,170.198,173.982,178.032,179.996,183.85,187.634,190.676,194.459,196.533,200.238,204.092,205.574,208.688,210.17,214.14499999999998,216.108,217.59,221.374,224.558,228.413,229.895,233.678,237.728,239.692,243.476,247.451,249.387,251.538,255.322,258.922,260.895,264.08,267.864,270.015,271.497" svgx:width="0.21,0.53,0.26,0.21,0.52,0.48,0.53,0.44,0.48,0.55,0.53,0.26,0.55,0.36,0.52,0.29,0.26,0.45,0.44,0.3,0.45,0.53,0.3,0.36,0.17,0.55,0.54,0.53,0.21,0.44,0.81,0.48,0.29,0.55,0.45,0.53,0.54,0.55,0.54,0.53,0.43,0.53,0.29,0.52,0.54,0.21,0.44,0.21,0.53,0.55,0.21,0.53,0.45,0.54,0.21,0.53,0.54,0.55,0.53,0.53,0.55,0.3,0.53,0.48,0.55,0.45,0.53,0.3,0.21,0.29" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Influence of surfactants, polymer and doxorubicin loading on the anti-</text>
  <text y="704.07" x="71.715,73.867,77.572,83.357,87.14,90.845,93.02,95.072,98.485,100.337,102.19,105.603,108.716,110.966,112.987,116.77,118.72,120.754,124.608,128.391,129.873,132.987,134.84,138.694,142.399,144.551,147.664,149.23899999999998,151.31,154.424,157.537,160.722,164.505,168.289,171.474,174.587,176.661,179.774,181.256,184.441,186.593,190.006,191.956,194.055,197.839,201.023,204.807,208.59,212.445,215.63,217.703,219.855,221.337,224.45,225.932,229.345,232.045,234.079,235.561,239.536,241.506,244.881,246.779,248.852,252.037,254.287,256.36,260.214,261.696,263.178,266.962,272.747" svgx:width="0.3,0.52,0.81,0.53,0.52,0.29,0.55,0.48,0.26,0.26,0.48,0.44,0.3,0.55,0.53,0.26,0.55,0.54,0.53,0.21,0.44,0.26,0.54,0.52,0.3,0.44,0.21,0.55,0.44,0.44,0.45,0.53,0.53,0.45,0.44,0.29,0.44,0.21,0.45,0.3,0.48,0.26,0.55,0.53,0.45,0.53,0.53,0.54,0.45,0.29,0.3,0.21,0.44,0.21,0.48,0.36,0.55,0.21,0.53,0.55,0.45,0.55,0.29,0.45,0.3,0.55,0.54,0.21,0.21,0.53,0.81,0.45" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma</text>
  <text y="713.084" x="71.715,77.5,81.284,85.138,88.551,90.033,91.308,93.314,95.86399999999999,97.906,103.392,104.874,107.988,110.061,113.845,117.257,121.041,124.154,127.339,131.194,133.787,137.492,138.974,140.249,142.352,145.765,149.178,152.591,156.003,157.186,160.599,164.012,165.194,168.607,172.02" svgx:width="0.81,0.53,0.54,0.48,0.21,0.17,0.55,0.34,0.55,0.77,0.21,0.44,0.29,0.53,0.48,0.53,0.44,0.45,0.54,0.36,0.52,0.21,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">model. J Microencapsul. 2006;23:582</text>
  <text y="713.084" x="175.464" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="713.084" x="178.978,182.391,185.804" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">92.</text>
  <text y="722.325" x="56.692,60.104,63.517,64.792,71.715,74.9,78.313,82.018,85.801,89.851,91.784,97.27,101.723,102.998,105.05,109.054,112.837,114.319,117.504,121.287,125.142,128.555,130.037,134.012,135.947,140.4,141.675,143.771,147.255,150.668,154.268,156.186,159.45,165.235,166.51000000000002,168.545,171.809,175.592,178.705,181.89,185.745,188.338,192.043,193.525,196.71,198.862,200.344,204.127,208.102,210.101,213.884,215.83399999999997,217.867,220.981,224.686,226.759,229.873,233.578,239.363,240.845,244.82,246.78,248.262,252.237,254.207,257.321,260.506,262.657,264.139,267.923,271.706,273.188" svgx:width="0.48,0.48,0.17,0.55,0.45,0.48,0.52,0.53,0.54,0.55,0.77,0.63,0.17,0.55,0.56,0.53,0.21,0.45,0.53,0.54,0.48,0.21,0.53,0.55,0.63,0.17,0.55,0.49,0.48,0.48,0.55,0.46,0.81,0.17,0.55,0.46,0.53,0.44,0.45,0.54,0.36,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.44,0.52,0.29,0.44,0.52,0.81,0.21,0.53,0.55,0.21,0.53,0.55,0.44,0.45,0.3,0.21,0.53,0.53,0.21,0.44" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">82. Leung MH, Colangelo H, Kee TW. Encapsulation of curcumin in cationic</text>
  <text y="731.339" x="71.715,77.5,78.982,82.096,85.509,86.991,88.473,91.886,94.586,96.603,99.197,102.901,106.756,110.611,112.684,116.097,118.69,121.284,124.697,127.397,129.427,132.612,134.094,137.058,140.243,141.725,143.207,146.99,150.59,152.558,156.341,159.455,163.309,165.383,169.166,170.648,173.761,176.355,177.837,180.43,181.705,183.795,186.98,190.164,193.948,197.802,203.588,207.293,208.775,210.848,212.12300000000002,214.182,217.595,221.007,224.42,227.833,229.016,232.429,235.841,237.694,241.107,244.52,246.372,247.555,250.968,254.38,257.793" svgx:width="0.81,0.21,0.44,0.48,0.21,0.21,0.48,0.36,0.55,0.36,0.52,0.54,0.54,0.29,0.48,0.36,0.36,0.48,0.36,0.55,0.45,0.21,0.42,0.45,0.21,0.21,0.53,0.48,0.55,0.53,0.44,0.54,0.29,0.53,0.21,0.44,0.36,0.21,0.36,0.17,0.55,0.45,0.45,0.53,0.54,0.81,0.52,0.21,0.29,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.26,0.48,0.48,0.26,0.17,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">micelles suppresses alkaline hydrolysis. Langmuir. 2008;24(11):5672</text>
  <text y="731.339" x="261.24" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="731.339" x="264.812,268.225" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">5.</text>
  <text y="95.358" x="304.724,308.137,311.55,312.825,319.748,323.902,327.685,333.47,336.883,340.933,342.878,346.362,347.637,349.681,352.866,354.441,356.484,360.046,361.32099999999997,363.344,368.83,371.943,375.948,377.43,380.842,386.628,390.041,393.824,395.976,398.676,400.76,405.356,407.8,409.075,411.135,414.989,416.471,419.656,423.63100000000003,425.591,430.044,431.31899999999996,433.358,437.882,441.067,444.851,448.634,452.047,457.832,461.537,463.019,465.613,467.095,470.878,474.661,476.735,479.919,483.703,487.753,489.71,493.123,498.908,502.613,504.095,506.688,508.17,511.954,515.737,517.81,521.665,524.85,527.443,530.856" svgx:width="0.48,0.48,0.17,0.55,0.58,0.53,0.81,0.48,0.54,0.55,0.49,0.17,0.55,0.45,0.21,0.55,0.5,0.17,0.55,0.77,0.44,0.56,0.21,0.48,0.81,0.48,0.53,0.3,0.36,0.55,0.64,0.34,0.17,0.55,0.54,0.21,0.45,0.53,0.55,0.63,0.17,0.55,0.63,0.45,0.53,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.29,0.45,0.53,0.54,0.55,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.29,0.54,0.45,0.36,0.48,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">83. Ahmed K, Li Y, McClements DJ, Xiao H. Nanoemulsion-and emulsion-based</text>
  <text y="104.315" x="319.748,323.602,327.015,328.497,329.979,333.164,336.577,338.65,341.95,343.898,346.492,349.605,352.199,354.351,357.763,363.549,366.24899999999997,368.276,370.128,373.911,376.086,378.14,381.254,384.959,387.032,390.145,393.85,399.636,401.118,404.901,406.176,408.243,411.656,415.44,418.553,421.738,425.593,428.186,431.891,433.373,436.558,438.71,440.192,443.975,447.95000000000005,449.912,453.097,456.88,460.93,462.894,464.968,468.381,469.863,473.275,476.46,479.054,482.654,484.608,488.462,490.535,494.319,498.173,501.586,503.66,505.811,507.293,510.706,513.3,514.5749999999999,516.638,519.901,523.685,527.468" svgx:width="0.54,0.48,0.21,0.21,0.45,0.48,0.29,0.44,0.55,0.36,0.44,0.36,0.3,0.48,0.81,0.36,0.55,0.26,0.53,0.29,0.55,0.44,0.52,0.29,0.44,0.52,0.81,0.21,0.53,0.17,0.55,0.48,0.53,0.44,0.45,0.54,0.36,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.55,0.45,0.53,0.54,0.55,0.29,0.48,0.21,0.48,0.45,0.36,0.48,0.55,0.54,0.29,0.53,0.54,0.48,0.29,0.3,0.21,0.48,0.36,0.17,0.55,0.46,0.53,0.53,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">delivery systems for curcumin: encapsulation and release properties. Food</text>
  <text y="113.329" x="319.748,323.752,327.535,330.948,336.734,338.00899999999996,340.043,343.456,346.869,350.282,353.694,354.877,358.29,361.703,365.116,366.968,370.381,372.234,373.416,376.829,380.242" svgx:width="0.56,0.53,0.48,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.26,0.48,0.26,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Chem. 2012;132(2):799</text>
  <text y="113.329" x="383.641" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="113.329" x="387.213,390.626,394.038,397.451" svgx:width="0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">807.</text>
  <text y="122.344" x="304.724,308.137,311.55,312.825,319.748,323.31,326.495,328.647,330.129,331.704,333.75,337.014,338.289,340.327,344.331,348.114,351.898,355.602,359.457,363.24,366.425,368.499,371.79900000000004,373.775,377.337,378.61199999999997,380.634,384.197,387.382,389.533,393.317,397.1,399.173,402.773,404.729,408.883,410.15799999999996,412.212,415.774,419.558,422.858,424.797,428.281,429.556,431.657,437.143,440.328,444.112,447.296,451.151,452.633,455.78299999999996,457.735,461.219,462.49399999999997,464.538,467.801,471.585,475.368,478.553,482.336,485.45,488.862,492.91200000000003,494.868,498.651,500.725,503.91" svgx:width="0.48,0.48,0.17,0.55,0.5,0.45,0.3,0.21,0.21,0.55,0.46,0.17,0.55,0.56,0.53,0.53,0.52,0.54,0.53,0.45,0.29,0.44,0.55,0.5,0.17,0.55,0.5,0.45,0.3,0.53,0.53,0.29,0.48,0.55,0.58,0.17,0.55,0.5,0.53,0.44,0.55,0.49,0.17,0.55,0.77,0.45,0.53,0.45,0.54,0.21,0.42,0.55,0.49,0.17,0.55,0.46,0.53,0.53,0.45,0.53,0.44,0.48,0.54,0.55,0.53,0.29,0.45,0.21" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">84. Patil S, Choudhary B, Rathore A, Roy K, Mahadik K. Enhanced oral</text>
  <text y="131.358" x="319.748,323.602,325.084,328.868,332.053,335.237,338.422,339.904,341.386,344.571,348.426,349.908,351.389,352.871,355.023,358.32300000000004,360.282,363.467,367.25,371.3,373.264,376.449,380.233,382.384,383.866,386.98,390.165,393.948,397.062,400.474,402.649,404.672,407.857,410.97,413.122,414.604,417.789,419.271,421.422,424.72200000000004,426.725,430.508,432.45799999999997,434.492,438.275,442.058,445.243,448.656,450.231,452.293,455.407,459.112,461.185,464.299,468.004,473.789,475.271,479.24600000000004,481.206,482.688,486.471,489.656,493.511,496.924,500.974,502.919,508.705,510.187,513.229,516.642" svgx:width="0.54,0.21,0.53,0.45,0.45,0.45,0.21,0.21,0.45,0.54,0.21,0.21,0.21,0.3,0.44,0.55,0.45,0.53,0.54,0.55,0.45,0.53,0.3,0.21,0.44,0.45,0.53,0.44,0.48,0.29,0.55,0.45,0.44,0.3,0.21,0.45,0.21,0.3,0.44,0.55,0.53,0.26,0.55,0.53,0.53,0.45,0.48,0.21,0.55,0.44,0.52,0.29,0.44,0.52,0.81,0.21,0.53,0.55,0.21,0.53,0.45,0.54,0.48,0.54,0.55,0.81,0.21,0.43,0.48,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">bioavailability and anticancer activity of novel curcumin loaded mixed</text>
  <text y="140.315" x="319.748,325.533,327.015,330.129,333.542,335.024,336.506,339.918,342.618,344.636,346.118,350.093,352.063,355.846,359.551,365.336,368.521,372.49600000000004,374.456,375.938,379.643,383.427,387.47700000000003,389.423,392.537,395.721,399.505,402.618,406.031,408.206,410.229,413.343,416.756,418.238,419.719,422.313,423.58799999999997,425.65,429.212,432.995,436.109,438.261,442.044,447.829,451.242,455.097,456.37199999999996,458.417,461.83,465.243,468.656,472.068,473.251,476.664,480.077,481.929,485.342,488.755,490.607,491.79,495.203,498.616,502.029" svgx:width="0.81,0.21,0.44,0.48,0.21,0.21,0.48,0.36,0.55,0.21,0.53,0.55,0.53,0.52,0.81,0.45,0.53,0.55,0.21,0.52,0.53,0.54,0.55,0.44,0.45,0.53,0.44,0.48,0.29,0.55,0.44,0.48,0.21,0.21,0.36,0.17,0.55,0.5,0.53,0.44,0.3,0.53,0.81,0.48,0.54,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.26,0.48,0.48,0.26,0.17,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">micelles in human lung cancer cells. Phytomed. 2015;22(12):1103</text>
  <text y="140.315" x="505.474" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="140.315" x="509.046,512.459,515.871,519.284,522.697,526.11" svgx:width="0.48,0.48,0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">11011.</text>
  <text y="149.329" x="304.724,308.137,311.55,312.825,319.748,323.011,326.196,330.05,333.834,337.434,339.363,341.807,345.37,346.645,348.718,352.202,355.387,358.351,362.056,367.841,371.026,374.809,378.709,380.692,383.955,385.22999999999996,387.268,392.014,394.087,396.239,397.721,400.721,402.689,407.284,408.55899999999997,410.569,413.832,417.616,421.028,424.403,426.386,429.65,430.92499999999995,432.963,437.487,438.969,442.083,445.866,447.348,451.131,453.725,455.3,457.34,460.902,463.346,464.621,466.694,471.04400000000004,472.987,476.77,479.955,483.738,487.522,490.934,496.72,500.425,501.907,504.5,505.982,509.766" svgx:width="0.48,0.48,0.17,0.55,0.46,0.45,0.54,0.53,0.48,0.55,0.34,0.5,0.17,0.55,0.49,0.45,0.42,0.52,0.81,0.45,0.53,0.52,0.55,0.46,0.17,0.55,0.67,0.29,0.3,0.21,0.4,0.55,0.64,0.17,0.55,0.46,0.53,0.48,0.45,0.55,0.46,0.17,0.55,0.63,0.21,0.44,0.53,0.21,0.53,0.36,0.21,0.55,0.5,0.34,0.17,0.55,0.58,0.55,0.53,0.45,0.53,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">85. Tagne JB, Kakumanu S, Ortiz D, Shea T, Nicolosi RJ. A nanoemulsion</text>
  <text y="158.343" x="319.748,321.6,325.384,327.457,333.242,336.947,338.429,341.614,343.766,345.248,349.031,353.00600000000003,354.953,358.737,360.687,362.72,364.872,368.057,373.842,377.626,380.668,382.15,384.002,387.415,391.39000000000004,393.334,394.816,398.599,401.713,403.786,407.199,410.384,412.977,416.39,419.09,421.169,422.651,424.803,427.503,429.503,432.916,434.769,436.621,438.103,441.217,444.402,447.515,450.815,452.804,454.286,458.261,460.231,463.606,465.56,469.415,471.488,474.901,478.086,480.68,482.93,484.949,488.062,491.247,495.031,498.144,501.557,503.732,505.811,508.925,512.338,513.82,515.3950000000001,517.433,518.915,520.397,524.181,527.594" svgx:width="0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.3,0.45,0.81,0.53,0.43,0.21,0.26,0.48,0.53,0.55,0.21,0.53,0.44,0.29,0.48,0.45,0.36,0.48,0.36,0.55,0.21,0.3,0.36,0.55,0.48,0.26,0.26,0.21,0.44,0.45,0.44,0.44,0.55,0.21,0.53,0.55,0.45,0.55,0.54,0.29,0.48,0.45,0.36,0.3,0.55,0.44,0.45,0.53,0.44,0.48,0.29,0.55,0.44,0.48,0.21,0.21,0.55,0.21,0.21,0.53,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">formulation of tamoxifen increases its efficacy in a breast cancer cell line.</text>
  <text y="167.357" x="319.748,325.234,329.017,330.592,332.617,336.179,339.963,343.147,345.221,351.006,352.28099999999995,354.33,357.743,361.156,364.568,367.981,369.164,372.577,374.429,377.842,379.695,380.877,384.29,387.703" svgx:width="0.77,0.53,0.21,0.55,0.5,0.53,0.45,0.29,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.26,0.48,0.26,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Mol Pharm. 2008;5(2):280</text>
  <text y="167.357" x="391.124" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="167.357" x="394.696,398.109" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">6.</text>
  <text y="176.314" x="304.724,308.137,311.55,312.825,319.748,323.011,325.084,328.789,330.271,331.846,333.864,338.018,341.502,342.777,344.862,348.126,351.31,355.285,357.221,360.705,364.189,368.194,369.469,371.507,375.96,378.034,380.186,382.259,383.741,387.595,391.45,395.05,397.019,399.463,400.738,402.801,406.364,409.549,413.254,416.667,418.842,420.886,424.149,425.424,427.462,431.616,433.098,436.511,439.553,442.738,446.521,450.376,453.789,455.964,458.019,462.393,464.837,470.323,471.59799999999996,473.666,476.11,479.294,485.08,486.562,489.975,492.568,496.351,500.326,502.295,506.819,510.382" svgx:width="0.48,0.48,0.17,0.55,0.46,0.29,0.52,0.21,0.21,0.55,0.58,0.49,0.17,0.55,0.46,0.45,0.53,0.55,0.49,0.49,0.56,0.17,0.55,0.63,0.29,0.3,0.29,0.21,0.54,0.54,0.48,0.55,0.34,0.17,0.55,0.5,0.45,0.52,0.48,0.29,0.55,0.46,0.17,0.55,0.58,0.21,0.48,0.43,0.45,0.53,0.54,0.48,0.29,0.55,0.61,0.34,0.77,0.17,0.55,0.34,0.45,0.81,0.21,0.48,0.36,0.53,0.53,0.55,0.63,0.5,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">86. Trull AK, Tan KKC, Urtridge J, Bauer T, Alexander GJM, Jamieson NV.</text>
  <text y="185.329" x="319.748,323.752,326.866,329.979,331.461,335.244,337.838,341.693,345.476,347.549,349.031,352.814,356.41400000000004,358.355,361.54,365.394,367.988,371.771,373.844,377.699,379.851,381.333,385.116,389.091,391.066,392.918,394.992,398.775,404.84999999999997,406.713,412.498,413.98,417.094,419.167,422.951,426.363,432.149,435.854,437.336,439.929,441.411,445.195,449.17,451.103,452.955,456.738,458.812,464.597,468.302,469.784,472.969,475.121,476.603,480.386,484.36100000000005,486.365,487.847,491.822,493.735,495.217,496.699,499.884,503.297,505.47200000000004,507.568,509.72,511.793,514.978,518.761,521.355,525.209,526.691,529.876,533.659" svgx:width="0.56,0.44,0.44,0.21,0.53,0.36,0.54,0.53,0.29,0.21,0.53,0.48,0.55,0.45,0.54,0.36,0.53,0.29,0.54,0.3,0.21,0.53,0.53,0.55,0.26,0.29,0.53,0.81,0.55,0.81,0.21,0.44,0.29,0.53,0.48,0.81,0.52,0.21,0.36,0.21,0.53,0.53,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.55,0.21,0.53,0.55,0.21,0.21,0.45,0.48,0.29,0.55,0.3,0.29,0.45,0.53,0.36,0.54,0.21,0.45,0.53,0.3" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Cyclosporine absorption from microemulsion formulation in liver transplant</text>
  <text y="194.343" x="319.748,321.821,325.234,328.348,329.83,333.684,335.166,338.579,342.362,344.514,345.789,347.81,350.995,354.18,357.963,361.077,364.489,366.641,367.916,369.976,373.389,376.802,380.215,383.628,384.81,388.223,391.636,395.049,396.232,399.645,403.057,406.47" svgx:width="0.29,0.48,0.44,0.21,0.54,0.21,0.48,0.53,0.3,0.17,0.55,0.45,0.45,0.53,0.44,0.48,0.3,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17,0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">recipient. Lancet. 1993;341:433.</text>
  <text y="203.357" x="304.724,308.137,311.55,312.825,319.748,324.201,327.984,329.466,331.716,333.75,338.346,344.131,345.40599999999995,347.47,352.956,356.661,360.074,361.556,363.038,366.451,368.62600000000003,370.657,373.92,378.074,379.349,381.371,384.855,388.639,391.823,395.008,397.082,398.564,401.714,403.708,406.152,411.638,412.91299999999995,414.989,418.174,421.359,425.334,427.292,430.854,432.928,436.34,439.94,441.862,444.305,447.868,449.143,451.216,454.7,458.405,460.557,463.557,465.502,468.986,470.26099999999997,472.305,475.568,479.351,482.951,484.89,488.745,492.528,495.713,497.786,503.572,506.757,509.87,513.654,516.617,518.099,521.883,525.296,527.447,528.929,532.043" svgx:width="0.48,0.48,0.17,0.55,0.63,0.53,0.21,0.3,0.55,0.64,0.81,0.17,0.55,0.77,0.52,0.48,0.21,0.21,0.48,0.29,0.55,0.46,0.58,0.17,0.55,0.49,0.53,0.45,0.45,0.29,0.21,0.42,0.55,0.34,0.77,0.17,0.55,0.45,0.45,0.53,0.55,0.5,0.29,0.48,0.48,0.55,0.34,0.5,0.17,0.55,0.49,0.52,0.3,0.4,0.55,0.49,0.17,0.55,0.46,0.53,0.48,0.55,0.54,0.53,0.45,0.29,0.81,0.45,0.44,0.53,0.42,0.21,0.53,0.48,0.3,0.21,0.44,0.36" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">87. Holt DW, Mueller EA, Kovarik JM, van Bree JB, Kutz K. The pharmacokinetics</text>
  <text y="212.315" x="319.748,323.531,325.481,327.515,330.778,333.963,337.746,341.601,343.083,348.868,354.653,358.358,362.333,364.308,368.832,372.245,376.028,378.102,381.286,382.768,384.04299999999995,386.077,389.452,391.407,395.19,398.603,404.003,405.863,409.646,411.72,414.905,416.47999999999996,418.505,420.358,424.141,426.215,432.0,435.705,437.187,440.372,442.523,444.005,447.789,451.764,453.767,457.551,459.501,461.534,464.648,467.761,470.875,472.357,476.14,478.734,482.588,486.372,488.445,489.927,493.71,497.123,498.39799999999997,500.481,503.744,505.818,509.002,512.786,515.379,519.234,520.716,523.901,527.684" svgx:width="0.53,0.26,0.55,0.46,0.45,0.53,0.54,0.21,0.81,0.81,0.52,0.53,0.55,0.63,0.48,0.53,0.29,0.45,0.21,0.17,0.55,0.45,0.55,0.53,0.48,0.72,0.55,0.53,0.29,0.45,0.21,0.55,0.26,0.53,0.29,0.81,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.44,0.44,0.44,0.21,0.53,0.36,0.54,0.53,0.29,0.21,0.53,0.48,0.17,0.55,0.46,0.29,0.45,0.53,0.36,0.54,0.21,0.45,0.53,0.3" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">of Sandimmun Neoral: a new oral formulation of cyclosporine. Transplant</text>
  <text y="221.329" x="319.748,323.31,325.384,329.167,332.28,333.55499999999995,335.565,338.978,342.391,345.804,349.216,350.399,353.812,357.225,359.077,362.49,364.343,365.525,368.938,372.351,375.764" svgx:width="0.5,0.29,0.53,0.44,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.26,0.48,0.26,0.17,0.48,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Proc. 1994;26(5):2935</text>
  <text y="221.329" x="379.219" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="221.329" x="382.79,386.203" svgx:width="0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">9.</text>
  <text y="230.343" x="304.724,308.137,311.55,312.825,319.748,325.533,328.946,330.521,332.561,335.745,337.02,339.08,342.343,346.048,350.023,351.949,355.511,356.786,358.865,363.389,364.871,368.471,370.374,373.637,374.912,377.007,380.57,383.754,387.72900000000004,389.65,395.435,396.71,398.777,402.34,404.413,407.826,411.681,414.865,416.939,420.124,422.275,423.757,427.541,431.516,433.473,436.658,440.441,444.491,446.455,449.868,453.053,456.238,457.72,461.424,464.609,466.761,468.243,472.026,476.00100000000003,477.976,481.759,483.709,485.742,489.006,492.269,496.864,501.46,504.90999999999997,506.888,510.073,513.857" svgx:width="0.48,0.48,0.17,0.55,0.81,0.48,0.21,0.55,0.45,0.17,0.55,0.46,0.52,0.53,0.55,0.5,0.17,0.55,0.63,0.21,0.48,0.55,0.46,0.17,0.55,0.5,0.45,0.53,0.55,0.81,0.17,0.55,0.5,0.29,0.48,0.54,0.45,0.29,0.45,0.3,0.21,0.53,0.53,0.55,0.45,0.53,0.54,0.55,0.48,0.45,0.45,0.21,0.52,0.45,0.3,0.21,0.53,0.53,0.55,0.53,0.26,0.55,0.46,0.46,0.64,0.64,0.46,0.55,0.45,0.53,0.54" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">88. Wei L, Sun P, Nie S, Pan W. Preparation and evaluation of SEDDS and</text>
  <text y="239.357" x="319.748,323.011,328.497,331.76,336.356,340.952,344.402,346.337,349.45,353.233,357.017,359.168,362.353,363.835,367.619,369.101,372.884,376.934,378.877,381.991,385.176,387.249,390.434,393.847,397.701,399.183,400.665,404.449,405.931,407.20599999999996,409.321,413.916,415.99,419.695,423.745,425.704,430.3,433.713,437.088,439.027,440.509,444.293,448.343,450.309,453.871,457.655,460.839,462.913,468.698,469.97299999999996,472.022,475.435,478.848,482.26,485.673,486.856,490.269,493.682,495.534,498.947,500.8,501.982,505.395,508.808" svgx:width="0.46,0.77,0.46,0.64,0.64,0.46,0.55,0.44,0.53,0.53,0.3,0.45,0.21,0.53,0.21,0.53,0.54,0.55,0.44,0.45,0.29,0.45,0.48,0.54,0.21,0.21,0.53,0.21,0.17,0.55,0.64,0.29,0.52,0.54,0.55,0.64,0.48,0.45,0.55,0.21,0.53,0.54,0.55,0.5,0.53,0.45,0.29,0.81,0.17,0.55,0.48,0.48,0.48,0.48,0.17,0.48,0.48,0.26,0.48,0.26,0.17,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">SMEDDS containing carvedilol. Drug Dev Ind Pharm. 2005;31(8):785</text>
  <text y="239.357" x="512.221" svgx:width="0.5" style="fill:rgb(19,20,19);font-family:JlmctvAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text y="239.357" x="515.792,519.205,522.618" svgx:width="0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:YhnyntAdvTTb5929f4c;font-size:7.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">94.</text>
  <text y="39.005" x="56.693,61.021,64.853,67.429,71.261,77.925,80.501,84.501,88.996,93.492" svgx:width="0.54,0.48,0.32,0.48,0.83,0.32,0.5,0.56,0.56,0.47" style="fill:rgb(19,20,19);font-family:XbkjggAdvTTe45e47d2;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Katamreddy</text>
  <text y="39.005" x="99.552,103.128,105.608,107.999,112.159,113.903,115.58300000000001,117.978,121.474,123.218,127.378,129.122,133.282,136.162,138.557,140.301,144.541,146.948,151.948,155.524,159.684,161.428,163.924,168.16400000000002,170.532,174.692,178.94,183.1,185.499,190.659,192.403,195.315,198.891,203.051,205.963" svgx:width="0.45,0.31,0.55,0.52,0.22,0.21,0.55,0.44,0.22,0.52,0.22,0.52,0.36,0.55,0.22,0.53,0.55,0.63,0.45,0.52,0.22,0.31,0.53,0.55,0.52,0.53,0.52,0.55,0.64,0.22,0.36,0.45,0.52,0.36,0.45" style="fill:rgb(19,20,19);font-family:BgxxryAdvTT7329fd89.I;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">et al. Lipids in Health and Disease</text>
  <text y="39.005" x="211.861,213.557,215.829,219.932,224.036,228.14,232.244,234.516,236.212,240.316,244.42,246.076,250.18,254.284,258.388" svgx:width="0.21,0.28,0.51,0.51,0.51,0.51,0.28,0.21,0.51,0.51,0.21,0.51,0.51,0.51,0.21" style="fill:rgb(19,20,19);font-family:MyriadPro-Regular;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> (2018) 17:112 </text>
  <text y="39.005" x="500.143,504.391,508.222,512.638,516.638,519.022,523.1020000000001,525.485,529.813,532.133,534.499" svgx:width="0.53,0.48,0.55,0.5,0.55,0.51,0.55,0.54,0.29,0.55,0.51" style="fill:rgb(19,20,19);font-family:XbkjggAdvTTe45e47d2;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Page 8 of 8</text>
 </g>
</svg>
